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Skeletal complications from radiation therapy have been described for breast, brain, 
pelvic, and blood cancers. These problems include atrophy, fractures, and 
osteoradionecrosis. Improved survivorship rates of cancer patients receiving radiotherapy 
increases the importance of understanding the causal mechanisms and long-term effects 
of radiation-induced bone loss. One such long-term effect is bone fractures following 
radiation therapy for cancer treatment. The incidence of hip fractures is significantly 
increased following targeted radiotherapy for cancer. This decline in bone health can 
have a severe impact on the patient’s functional capabilities. This damage to bone 
following irradiation is thought to involve damage to both osteoblasts and vascularity 
within bone. However, the relationship between radiation and osteoclast activity (bone 
resorption) is unknown and poorly studied. Very few studies have examined the effects of 
radiation on osteoclast number and activity, and those that have reveal conflicting results. 
The studies presented herein will examine the response of bone to ionizing radiation in 
order to assess if radiation can increase osteoclast activity. The primary goal is to 
determine if increased osteoclast activation and number occur as a result of exposure to 
ionizing radiation, thus contributing to radiation-induced osteoporosis.  Our hypothesis is 
that exposure to ionizing radiation increases osteoclast activity and number, resulting in 
elevated resorption early after exposure. 
The results from these studies indicate that exposure to ionizing radiation can induce 
osteoporosis within two weeks of treatment. The degree of bone loss at this point is 






number and function as determined by in vitro assays is likewise increased during the 
first two weeks of treatment. Histological evidence identifies an increase in the surface of 
irradiated trabeculae covered by osteoclasts by three days after treatment. Serum proteins 
indicate overall whole-body increase in resorption by only one day after exposure.  
Similar patterns of reduced bone volume and microarchitecture are observed in irradiated 
rat tibia by two weeks after treatment with doses of X-rays modeling what human pelvic 
bones might receive during cancer treatment. Administration of bisphosphonates largely 
mitigates these changes. Thus ionizing radiation increases bone resorption within these 
animal models early after exposure. 
Future studies must more specifically identify how radiation induces osteoclast 
activation. This information can then be used to identify targets to suppress bone 
resorption after irradiation. Ultimately, these data need to be correlated with the effects of 
radiation on bone strength and how radioprotective (or antiresorptive) agents can 
influence this response. These investigations may prove useful in eventually reducing the 
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CHAPTER 1:  PROJECT RATIONALE 
 
1.1 Clinical Concern 
Skeletal complications from radiation therapy have been described for breast, brain, 
pelvic, and blood cancers. These problems include atrophy, fractures, and 
osteoradionecrosis. Improved survivorship rates of cancer patients receiving radiotherapy 
increases the importance of understanding the mechanisms and long-term effects of 
radiation-induced bone loss. In a recent study of more than 6,000 women over the age of 
65 treated for cervical, rectal, and anal cancers, it was reported that radiation therapy 
significantly increased the risk of pelvic fracture (relative risks of 1.66, 1.65, and 3.16, 
respectively, for cervical, rectal, and anal cancers) (Baxter et al., 2005a). Radiation thus 
compromises bone health and can have a severe impact on patients’ functional 
capabilities. The damage to bone following irradiation is thought to involve changes to 
both osteoblasts and vascularity within bone (Dudziak et al., 2000; Hopewell, 2003; 
Sakurai et al., 2007). However, the relationship between radiation and osteoclast activity 
(bone resorption) is unknown and poorly studied. 
 
1.2 General Hypothesis 
The general hypothesis for this dissertation is that radiation increases osteoclast 
activity. An increase in resorption via radiation-induced stimulation of osteoclast number 
or activity may represent a component of the atrophy observed in bone following 
irradiation (Figure 1.1). Our intent is to use an animal model in order to describe the 






architecture, and cellular responses. The approach for examining this hypothesis includes: 
1) Establishing that atrophy occurs after both directly irradiating bone as well as from 
within bone shielded from otherwise total body irradiation; 2) Determine if atrophy 
occurs at very early (days), early (weeks) and late (9 month) time-points; 3) Collect in 
vitro and in vivo evidence that osteoclast activity or number has increased; and 4) 
Examine the response of irradiated bone after resorption has been blocked by an 
osteoporosis therapy.  
 
Figure 1.1. Proposed causes for observed reduction in bone mass following 
irradiation. Vascular and osteoblast damage, leading to bone damage and loss of 
bone mineral density, are well documented. We propose that an increase in 
osteoclast activity (i.e. bone resorption) occurs concurrently with cellular and tissue 














1.3 Specific Aims 
1.3.1 Aim 1 
Evaluate the trabecular and cortical bone response (i.e., connectivity, bone volume, polar 
moment of inertia) in a bone that has been shielded from exposure to a source of radiation 
present within the spaceflight environment (56Fe26+). 
 
1.3.2 Hypothesis Aim 1 
Bone atrophy occurs as a long-term systemic effect after exposure to spaceflight-
relevant radiation exposure. 
 
1.3.3 Approach Aim 1  
Using male Sprague-Dawley rats and excluding the hind limbs and pelvis, we 
irradiated the animals with doses of 0, 1, 2, and 4 Gray (Gy) 56Fe26+ (n = 10 each) and 
euthanized them after 9 months. From these shielded bones. histomorphometric indices 
and serum markers for bone resorption were quantified via microcomputed tomography 
(microCT) and ELISA. Mineralization data, indicative of overall bone turnover, was 
determined via ashing. 
 
1.3.4 Aim 2  
Quantify bone volume, connectivity, and general histomorphometric parameters for 






whole-body (no shielding provided) dose of 7 Gy γ-radiation, equivelant to the dose 
administered prior to stem cell transplantation. 
 
1.3.5 Hypothesis Aim 2   
Exposure to a single, high dose of γ-radiation would result in an observable difference 
in bone following exposure even at a short time-point post exposure, likely the initial 
stages of atrophy characteristic of bone irradiation.  
 
1.3.6 Approach Aim 2  
Nine-week old C57BL/6 mice (n = 6) received 7 Gy γ-radiation, with nonirradiated 
controls (n = 6). After two weeks the animals were euthanized, hind limbs removed, and 
tibiae analyzed via microCT for histomorphometric parameters (i.e. bone volume, 
trabecular connectivity). Standard histological analysis of the metaphysis evaluated 
osteoclast and osteoblast surfaces as well as presence of osteoclasts (TRAP staining) to 
provide insight into overall turnover status of the bone.  
 
1.3.7 Aim 3  
Examine osteoclast presence, number, and activity within the tibia (histologically) 









1.3.8 Hypothesis Aim 3  
Osteoclast number (both in vivo and in vitro) and in vitro resorption will be 
substantially elevated at a very early time point-post exposure. 
 
1.3.9 Approach Aim 3   
A single 2 Gy dose of X-rays (similar in dose to a single fraction during radiotherapy) 
was delivered to two groups of mice, n = 6 each. After 1 day, one set of mice was 
sacrificed, and marrow plated on chamber slides and hydroxyapatite disks to measure the 
effect of irradiation on osteoclast proliferation and resorption. After 3 days, another set of 
mice was sacrificed, and hind limbs were evaluated via microCT and histology to 
quantify bone resorption and osteoclast presence. 
 
1.3.10 Aim 4  
Examine the response of irradiated bone after resorption has been blocked by an 
antiresorptive osteoporosis treatment. 
 
1.3.11 Hypothesis Aim 4   
Radiation therapy results in increased osteoclast activation and turnover, and thus 









1.3.12 Approach Aim 4 
In collaboration with Dr. Michael Robbins in the Radiation Oncology Department at 
Wake Forest University, we irradiated three sets of rats (n = 24 per group). Each rat 
received 16 Gy total administered to a single hind limb (right) in twice-weekly fractions 
of 4 Gy; this represents a biologically equivalent dose for human exposure to the hip for 
pelvic cancers. One irradiated group received administration of risedronate (0.04 
µg/kg/day), the other received placebo (PBS). Rats from each group (n = 12) were 
sacrificed at 2 and 4 weeks post-treatment. Non-irradiated control rats (+ placebo) were 








CHAPTER 2:  GENERAL BACKGROUND 
 
 
2.1 Background Information on Bone and the Chemical and Cellular Impacts of 
Exposure to Ionizing Radiation  
 
2.1.1 Bone Constituents 
Bone is a material composed of an organic matrix (approximately 35% of mammalian 
bone) and a mineral component (50-70% of bone) (Currey, 2002; Robey and Boskey, 
2006). The organic matrix is almost entirely (90-95%) composed of the structural protein 
collagen. The remainder is cells and ground substance of extracellular fluid and 
proteoglycans, including chondroitin sulfate and hyaluronic acid. The mineral component 
of bone is primarily calcium salts. The majority of the crystalline salts are in the form of 
hydroxyapatite (Ca10(PO4)6(OH)2) and are deposited within the organic matrix, bound to 
the collagen fibers. Other ions are present throughout bone, including magnesium, 
sodium, potassium, and carbonate ions. As such, approximately 99% of the body’s 
calcium is stored within bone (Specker, 1996). 
Collagen represents the most abundant protein in vertebrates and about 85-90% of the 
total protein in mature bone. Specifically, type I collagen is found within bone (Currey, 
2002; Robey and Boskey, 2006; Viguet-Carrin et al., 2006). The collagen protein consists 
of multiple fibrils of the polypeptide tropocollagen. Each tropocollagen protein is made 
of three chains consisting of 2 identical α1 chains and an α2 chain, all of which are 






held together by stable trivalent bonds (cross-links) to form microfibrils of procollagen, 
which further aggregate and mature to form collagen (Figure 2.1). Non-collagenous 
protein present in bone matrix include chondroitin sulfate, proteoglycans (decorin and 
biglycan), osteonectin, osteopontin, bone sialoprotein, albumin, and osteocalcin (Davison 
et al., 2006; Robey and Boskey, 2006).   
Specialized cells and coverings surround and reside within bony structures of the 
body. The outer surface of bone is surrounded by periosteum, a highly vascular and 
innervated double membrane consisting of a sheet of fibrous connective tissue with an 
inner cellular layer (Figure 2.2) (Dempster, 2006; Martini, 2004). The inner surface of 
bone is lined by a thin membrane of cells referred to as endosteum. The cells within the 
bone coverings and embedded within bone include osteoprogenitors, osteoclasts, 
osteoblasts, osteocytes, and bone lining cells. 
Two main types of bone that exist in mammals are woven and lamellar bone. Woven 
bone is bone that has been deposited rapidly, particularly in the developing fetus and 
during fracture repair. Collagen fibrils are randomly oriented throughout the bone, as is 
the arrangement of the crystals. Likewise the distribution of osteocytes within the bone is 
random (Jee, 2002). Woven bone will ultimately be resorbed and replaced with lamellar 
bone. Lamellar bone is more highly organized than woven bone, consisting of sheets 
(termed “lamellae) of collagen and minerals (Figure 2.3A). Collagen fibers run 
approximately in the same direction within individual domains found within each lamella 







Figure 2.1 The biosynthesis and organization of a crosslinked collagen fiber. 








Figure 2.2 Connective tissue coverings and bone cell linings of the periosteal and 




Cells (osteocytes) exist within both woven and lamellar bone (Jee, 2002). Lacunae are 
interconnected via canals (canaliculi) that extend throughout the bone (Figure 2.3B). 
Cytoplasmic extensions within canaliculi connect adjacent osteocytes via gap junctions, 
allowing communication with other bone cells as well as vasculature of the marrow and 
throughout the bone. Within mature lamellar bone these structures can exist as part of 
secondary osteons (Figure 2.3B). Osteons represent distinct structural units in which cells 
arising from different developmental sources, referred to as the basic multicellular unit 






2006). Vascular channels called perforating (Volkman’s) canals connect secondary 
osteons.  
The skeleton can be divided into two main subtypes: axial and appendicular. The 
axial skeleton includes the skull, vertebrae, ribs, and sternum. The appendicular skeleton 
includes the support elements for the axis, including limbs and limb girdles. The 
classification of bones within these two categories is varied, depending on shape or 
developmental origination of the bone. Shape of bones will be used as the designate for 
this review, with bones being described as flat (i.e. skull, scapula, and bones of the 
innominate such as the ilium), long (including tibia, femora, and humeri), short (carpals 
and tarsals), irregular (vertebrae), sesamoid (patella),and wormian (intrasutural) (Martini, 
2004).  
Long bones support the body and resist much of the loads imparted during 
locomotion and normal activity, and as such will be considered in detail herein. The 
typical long bone consists of a cylindrical shaft, called a diaphysis, and two widened 
ends, termed epiphyses (Figure 2.3C). The epiphyses are generally enlarged and rounded 
and serve as articular surfaces with adjacent bones. In growing individuals a growth plate 
is present as hyaline cartilage, or epiphyseal cartilage, at the ends of the bone. This plate 
is fully ossified in adults, forming the epiphyseal plate. The metaphysis is a region of 
primarily trabecular bone between the epiphyseal plate and the diaphysis, functionally 
connecting the epiphysis to the diaphysis. Both epiphyseal and diaphyseal surfaces are 













Figure 2.3.  The structural organization of bone: A) the osteon and organization of 
collagen within lamellae; B) secondary osteons within cortical and trabecular bone; 
and C) the anatomy and distribution of cortical and trabecular bone within a long 








Mature lamellar bone exists in two forms, cortical and trabecular (also termed 
“cancellous” or “spongy”) bone (Figure 2.3A,B and Figure 5). Cortical bone is a dense 
form of bone with little porosity comprising approximately 80% of the skeletal mass, and 
serves the main supportive role in the body (Jee, 2002). This type of bone is found 
primarily in the diaphyses of long bones and the outer shell of all bones (Figure 2.3 and 
2.4). Cortical bone consists of three types of lamellae, including: 1) concentric lamella of 
circular layers surrounding a central vascular canal, comprising a Haversian system; 2) 
circumferential lamellae consisting of continuous layers around the entire shaft (or 
diaphysis) of bone, and; 3) fragments of former concentric or circumferential lamella 
between existing lamella (Figure 2.3A and B) (Baron, 2003; Currey, 2002).  
Trabecular bone comprises approximately 20% of the skeletal mass, however it 
accounts for nearly 70% of bone surface (Jee, 2002). This highly porous form of bone 
exists as a mesh-like lattice of struts within the interior of bones (Figure 2.3 and 2.4). 
These struts, or trabeculae, exist as rods or plates found within the ends of long bones 
(filling the epiphyses and metaphyses) or between the cortical shell of flat or irregular 
bones. The individual spicules of trabecular bone are composed of interstitial lamella, 
with osteons having saucer-shaped stacks of primary lamellar bone (Currey, 2002; 
Dempster, 2006). Typically trabecular bone is less mineralized than cortical bone 
(Heaney, 2003). It should be noted that the percentage of cortical versus trabecular bone 
is bone and site specific, such that vertebrae are primarily (~75%) trabecular bone, the 






bones (such as the femoral head) are about equal in cortical and trabecular content 
(Dempster, 2006). 
 
Figure 2.4.  The distribution of cortical and trabecular bone within the metaphysis 
of a long bone (left) and a flat bone of the skull (right). Reproduced from (Martini, 
2004).  
 
2.1.2 Bone Cells 
The mature osteoclast is responsible for resorption of skeletal elements. These 
multinucleated cells develop from myeloid progenitor cells, which will also give rise to 
the monocyte / macrophage lineage (Blair et al., 2006; Horowitz et al., 2005; Lam et al., 
2000). Mature osteoclasts result from the fusion of these hematopoietic mononuclear 
cells (Figure 2.5) (Stenbeck, 2002; Väänänen and Zhao, 2002). The bone marrow 
macrophage appears to be the primary precursor (Ross, 2006). Prior to resorbing bone, 
osteoclasts are mobile cells that will migrate to surfaces to be resorbed (Stenbeck, 2002).   
The osteoclast is a multinucleated cell with a unique morphology related to the 
function of bone resorption. Two key features of functional osteoclasts, namely a series 
of villi-like extensions of the bone-apposed plasma membrane (termed a “ruffled 






on an actively resorbing osteoclast (Hurst et al., 2004; Stenbeck, 2002). A distinct 
microenvironment is created between the osteoclast and the bone surface during 
resorption, preventing digestive enzymes and protons from escaping into the surrounding 
extracellular fluid and permitting an environment optimal for protease activity. To 
establish this resorption compartment, a dense band of actin forms along the bone-
apposed plasma membrane due to cytoskeletal rearrangement. Adhesion of the osteoclast 
to the bone occurs via the formation of podosomes present within the actin rings, 
establishing a sealing zone (Ross, 2006; Stenbeck, 2002). The podosomes on osteoclasts 
consist of actin proteins with attached integrins, the primary functional receptor of these 
cells (Chellaiah, 2006; Zaidi et al., 2003). Integrins α2β3 of the podosome will bind to 
extracellular matrix proteins containing Arg-Gly-Asp (RGD) motifs, such as osteopontin, 
bone sialoprotein, and vitronectin (Väänänen and Zhao, 2002).  
The ruffled border is formed when vessicles containing enzymes involved with bone 
resorption (i.e. cathepsin K and matrix metalloproteases) fuse to the cell membrane 
adjacent to the bone (Ross, 2006). Proton pumps embedded in the membrane of the 
ruffled border, such as the vacuolar-type proton ATPase (V-ATPase), will function to 
release H+ ions into the space between the osteoclast and the bone. Proteases will digest 
collagen and bone matrix in this acidic microenvironment between the osteoclast and the 
bone. Lysosomal proteases are involved in the digestion of matrix and include: cathepsin 
K; tartrate-resistant acid phosphatase (TRAP); and matrix metalloproteases (MMPs) such 
as MMP-1, MMP-9, and MT1-MMP (Dempster, 2006; Drake et al., 1996; Ross, 2006). 






al., 2003). The digestion of the matrix forms a saucer-shaped resorption cavity on the 
surface of the bone, often referred to as a Howship’s lacuna (Figure 2.6).  
 
Figure 2.5. The development of osteoclasts (A) and osteoclasts (B), including 
expression of transcription factors and cytokines necessary for differentiation, 
proliferation, and maturation throughout the process. Reproduced from (Robling et 
al., 2006).   
 
 
Osteoblasts are cells responsible for the production of new bone. Osteoblasts 
originate from mesenchymal cells that differentiate into multipotential progenitors within 
the marrow (Figure 2.5) (Aubin et al., 2006). These progenitors form committed 
progenitors via production and activation of several factors, including osteoblast 
stimulating factor-1, IGF and PTH (Aubin et al., 2006). In the case of osteoblasts, the 






TGFβ (early differentiation) and bone morphogenic proteins (BMP)-2 and -9, otherwise 
the stem cell may commit to a progenitor for myocytes, chondrocytes, adipocytes, or 
stromal cells (Bai et al., 2004; Horowitz et al., 2005; Kanaan and Kanaan, 2006; Komori 
et al., 1997; Lian et al., 2004).   
Fully differentiated osteoblasts secrete primarily collagenous osteoid, which 
mineralizes over time to form mature bone. On the bone surface, osteoblasts are attached 
to one another via adherens junctions consisting of cadherins, tight junctions, and 
desmosomes (Aubin et al., 2006). Bone formation follows resorption by osteoclasts, such 
that once resorption has occurred, a signal initiates the recruitment and function of 
osteoblasts (Dempster, 2006). The nature of the signal is currently unclear, although 
various growth factors have been considered and can induce osteoblast differentiation 
and activation, including TGFβ, IGF-1, BMP’s, platelet derived growth factors (PDGFs), 
and fibroblast growth factors (FGFs) (Dempster, 2006; Siggelkow et al., 1999). 
Collagenous matrix (osteoid) is initially secreted, followed by deposition of minerals. 
Following formation, the majority of the osteoblasts will die via apoptosis, but many will 
become entrapped in the matrix and serve a role maintaining bone as osteocytes existing 
within empty lacunae, or remain present on a quiescent bone surface as flat bone lining-
cells (Walsh et al., 2003). 
2.1.3 Bone Remodeling 
Despite the seemingly static nature of this generally stiff material, bone is a dynamic 
tissue. Various portions of the skeleton are undergoing resorption while others are 






conditions (i.e. osteoporosis and bone malignant metastases) the rate of bone formation is 
equal to the resorption rate of mature bone (Blair et al., 2006; Gass and Dawson-Hughes, 







Figure 2.6.  Diagram of an active multinucleated osteoclast after having created a 




with subsequent replacement with new bone (Dempster, 2006). Trabecular bone is 
considered more metabolically active as the rate of remodeling, or turnover rate, is 
considerably higher than cortical bone. An estimated 15-20% of trabecular bone is 
remodeled per year (van der Linden et al., 2001). The remodeling of bone serves several 
roles in the skeleton. First, the skeleton will respond to loading (particularly strain) by 
changing size, shape, or matrix constituents (Bouxsein, 2005). The process also allows 
for replacing older, less mechanically sound bone (e.g. via damage or increased 






models indicates that reducing the turnover rate using osteoporosis countermeasures can 
lead to increased mineralization and microdamage (microfractures) within bones, as will 
be highlighted later in this literature review on page 33 (Burr et al., 2003; Mashiba et al., 
2000). However the sites of remodeling within bone are significantly associated with 
areas of microfractures, indicating that remodeling can target and repair damage (Burr, 
2002b; Noble, 2003). Second, as bone serves as a mineral storage site, remodeling 
permits the release of minerals such as calcium and phosphorus (Dempster, 2006). 
Bone remodeling is a tightly controlled process – excess bone loss or formation can 
result in structural or functional deficiencies (Blair et al., 2006; Parfitt, 1984). The 
process of bone remodeling is typically considered coupled, as osteoclastic resorption 
occurs prior to osteoblastic formation (Figure 2.7)  (Fink Eriksen et al., 2007; Mundy et 
al., 2003). The process by which this occurs is typically activation of cells necessary to 
resorb bone, followed by resorption, and then subsequent formation (Baron, 2003; 
Robling et al., 2006). Discrete areas of bone are remodeled by cells of the BMU.  
Osteoclasts of the BMU move through bone, resorbing tissue at approximately the 
diameter of the secondary osteon which will eventually be reformed, forming an effective 
tunnel within the bone (Robling et al., 2006). Behind the osteoclasts are mononuclear 
cells which line the resorption surface.  The function of these cells is unclear, though they 
may smooth off the scalloped edges of the Howship’s lacunae. The final layers are 
comprised of osteoblast which lay down unmineralized osteoid.  
Deposition of new bone occurs at the periphery of the resorption tunnel. As more 






ultimately forming the mature lamella of a secondary osteon. A canal will remain within 
the center of the of the concentric lamella if the BMU are remodeling an Haversian 
system within cortical bone, however the process of remodeling is very similar between 
cortical and trabecular bone (Dempster, 2006; Robling et al., 2006). The entire osteon 
will be separated from the rest of the bone by a cement line. Mineralization of the osteoid 
occurs 5-10 days following the deposition of osteoid with secondary mineralization 
continuing for years to decades (Davison et al., 2006). Primary mineralization occurs as 
membrane-bound bodies released by osteoblasts  localize calcium and phosphate ions as 
well as provide a nucleation core of proteins, ions, and acidic phospholipids that induce 
the formation of hydroxyapatite (Robey and Boskey, 2006). How these minerals localize 
at discrete areas on collagen is unknown.  
 
Figure 2.7.  The bone remodeling cycle, from activation of osteoclast to formation of 
new bone via osteoblasts.  Reproduced from 
http://www.umich.edu/news/Releases/2005/Feb05/bone.htm. 
 
2.1.4 Bone Biomechanics 
A function of bone is to resist loads applied to the body. (Bouxsein, 2005; Turner, 






of the applied load. Bone is an anisotropic material and thus exhibits different mechanical 
properties depending on the direction of the load (Cullinane and Einhorn, 2002). Bone 
fragility (or the susceptibility to fracture) under loading, imparted both from normal daily 
loads such as walking or during traumatic events like falling, is dependent on several 
factors. These factors include strength, brittleness, and work to failure (Turner, 2002). 
Indeed, strategies to reduce risk of fracture involve reducing loads applied to bones as 
well as increasing bone strength. The determinants of bone strength can be grouped into 
two categories, namely structural (e.g. mass and distribution of bone) and material (e.g. 
matrix constituents and microdamage) properties of bone (Bouxsein, 2005; Felsenberg 
and Boonen, 2005). 
 
2.1.5 Structural Properties:  Bone Mass 
Structural properties of bone are a function of the amount and distribution of bone 
(Bouxsein, 2005; Felsenberg and Boonen, 2005). The measurement of bone mass within 
a particular sample is the strongest determinant of strength and is referred to as bone 
mineral density (BMD), a measurement of mass per area despite the implication that this 
is a volumetric measurement (Ammann and Rizzoli, 2003). Typically this measurement 
is determined as the amount of hydroxyapatite scanned by dual-energy X-ray 
absortiometry (DXA) per unit area (Stauber and Muller, 2006; Turner, 2002). 
Quantitative computed tomography (QCT), or magnetic resonance imaging (MRI), can 
measure volumetric and areal bone mineral density. However, BMD itself only can 






determinants of bone strength other than BMD (including other structural and mineral 
properties) are defined as bone quality (Burr, 2004)  
 
2.1.6 Structural Properties:  Bone Shape 
The shape of long bones assists with the function of resisting loads applied to the 
body. Long bones are strongest in resisting compressive loads  (Cullinane and Einhorn, 
2002).  Bones are weaker in tension, but weakest in resisting shearing loads. However, 
limb bones are loaded primarily by bending moments (Rubin and Rubin, 2006), resulting 
in a complex and dynamic combination of axial tension and compression in addition to 
shear. The distribution of bone can help deal with these loading regimes, particularly in 
resisting bending (Bouxsein, 2005; Burr and Turner, 2003; Forwood, 2001). A diaphysis 
morphologically can resemble a hollow tube-like structure, maintaining strength while 
reducing weight.  The area moment of inertia (Ixx, Iyy or Imin, Imax), a predictor of 
resistance to bending in two directions (i.e. medial/lateral; anterior/posterior), of a cross 
section from this “tube” can be increased by distributing mass farther away from the 
neutral axis (Burr and Turner, 2003; Rubin and Rubin, 2006) (Figure 2.8). Thus having a 
given amount of bone, by distributing the mass farther from the neutral axis and making 
the tube hollow, the resistance to bending will increase while minimizing weight of the 
bone. Polar moment of inertia (J) , resisting torsion, will increase as well as it is closely 








Figure 2.8.  Three models representing cross-sectional bone architecture displaying 
that for a given area, by distributing bone away from the neutral axis of bending, 
the second moment of area (area moment of inertia) and thus resistance to bending 
increases. Modified from (Burr and Turner, 2003). Areas not drawn exactly to scale. 
 
The mass and mechanical properties of bone can also be influenced by pores within 
the cortical bone, referred to as cortical porosity. Pores such as lacunae, canaliculi, and 
vascular canals exist as necessary physiological structures; however resorption cavities 
during remodeling can generate cortical porosity as well (Augat and Schorlemmer, 2006; 
Mundy et al., 2003). Small increases in porosity will decrease Young’s modulus and can 
lead to large decreases in strength, as porosity number and diameter account for 
approximately 55% of yield stress and 70% of Young’s modulus in cortical bone (Augat 
and Schorlemmer, 2006; Davison et al., 2006). As such, BMD and porosity are large 
determinants of cortical bone strength and stiffness (Bouxsein, 2005). Unfilled resorption 
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sites can also serve as sites for stress concentration, perhaps leading to microdamage (see 
below) (Seeman and Delmas, 2006). 
The highly porous meshwork of trabecular bone consists of bony struts resembling 
plates and rods (Figure 2.9). The amount of trabecular bone is typically provided as a 
three-dimension value and represented as the volume of bone per given unit volume, or 
bone volume fraction (BV/TV) (Bouxsein, 2005). The volume fraction can be determined 
from samples using microcomputed tomography (microCT). Alignment of these rods and 
plates roughly follow the orientation of the greatest stresses and at right angles with one 
another, exhibiting an example of Wolff’s law (Currey, 2002; Robling et al., 2006).  
Struts transfer forces applied to the enlarged ends of long bones at joints down 
through the metaphysis into the cortical bone of the diaphysis, which is then loaded in 
compression and bending (Burr and Turner, 2003; Felsenberg and Boonen, 2005). The 
vertical trabeculae within the network act as beams transferring loads during 
physiological loading (bending and compression), with horizontal trabeculae connecting 
adjacent vertical struts and maintaining efficient force distribution (van der Linden et al., 
2001). Trabecular bone serves a similar role of energy dissipation in flat or irregular 
bones. Overall, trabecular bone can experience greater strains than cortical bone, and has 
a lower Young’s modulus (fracture at approximately 7% strain as opposed to 2% in 







Figure 2.9.  Four samples of trabecular architecture reconstructed from microCT 
measurements from: a) bovine proximal tibia, b) human proximal tibia; c) human 
femoral neck; and d) vertebral trabecular bone from a human.  Note the presence of 
plate-like and rod-like trabeculae. Reproduced from (Keaveny et al., 2001).   
 
Trabecular architecture refers to the interconnectivity of the trabeculae, as well as 
morphology of the struts (i.e. thickness, plate-like or rod-like), and orientation 
(Felsenberg and Boonen, 2005). Plates are  associated with increased mechanical strength 
in the direction of bending (Stauber and Muller, 2006). The alignment of the trabeculae 






direction of alignment (Robling et al., 2006). Trabecular bone within the femoral neck are 
strongest in resisting compression parallel to the long axis, whereas trabeculae within the 
vertebrae are strongest in resisting compression perpendicular to the long axis (Cullinane 
and Einhorn, 2002).  
The BV/TV of bone in a given trabecular architectural sample is critical in 
determining bone strength (Davison et al., 2006).  The ultimate strength of trabeculae in 
compression is related to the product of the apparent density (or the product of the 
density of the indivual trabeculae and the BV/TV) so reduction in volume fraction would 
result in a large decrease in compressive strength (Benhamou, 2006; Cullinane and 
Einhorn, 2002; Keaveny and Hayes, 1993).  
Loss of trabecular volume results in a loss of strength, with very elevated non-linear 
loss of strength at very low bone volumes (Davison et al., 2006). But other architectural 
factors besides BV/TV have an impact on bone strength. The connectivity of the struts 
and the number and thickness of trabeculae can affect efficient transfer of forces 
throughout the bone. The greater the trabecular connectivity, the shorter the length of the 
unsupported vertical (load-supporting) strut length.  The strength of the trabecular bone 
strut is inversely proportional to the square of the unsupported length (Currey, 2002; 
Davison et al., 2006), and is not dissimilar from Euler’s Buckling Theorem. A loss of 
horizontal trabeculae can increase the length of unsupported vertical trabeculae, which 
experience greater physiological stresses (van der Linden et al., 2001). Thus by 
increasing the length of existing vertical trabeculae by reducing connectivity, the critical 






For a similar loss in bone mass, reduction in connectivity of struts causes a substantial 
greater loss of bone strength and Young’s modulus than thinning of the struts (Guo and 
Kim, 2002; Seeman and Delmas, 2006; Silva and Gibson, 1997). Finite element models 
indicate that once trabecular numbers and connectivity are reduced, bone strength cannot 
recover due to increased thickness (Guo and Kim, 2002). Evidence suggests complete 
fractures of trabeculae resulting in loss of connectivity are not repaired (van der Linden et 
al., 2001). In patients with osteopenia (reduced bone mineral density), individuals with 
vertebral fractures had 4 times the numbers of complete fractures of individual trabeculae 
(Aaron et al., 2000). Thus the integrity of the trabecular microarchitecture is necessary to 
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Figure 2.10. Two models of trabecular architecture exhibiting how reduction in 
connectivity of horizontal trabeculae will result in an increased length of 
unsupported vertical struts.  
 
Thinning of the microarchitecture can cause stress concentrations to build at the site 






in depth can be present within a strut that may be only 100 µm deep (Hernandez et al., 
2006; van der Linden et al., 2001). Excessive remodeling will, through the accumulation 
of resorption pits, transform trabecular plates into trabecular rods. Finite element models 
have shown that resorption cavities can have a significant impact on trabecular bone 
strength, particularly in regions of high strain (Hernandez et al., 2006). The loss of bone 
through resorption pit accumulation can have a greater impact than by thinning of the 
trabeculae: a 20% loss of BV/TV due to resorption pits can result in a greater reduction in 
overall trabecular network stiffness (50%) than by thinning (30%) (van der Linden et al., 
2001). High stresses and strains are experienced at these sites and can increase chance of 
buckling and failure of the trabeculae. Cracks can initiate at sites of microfracture, further 
reducing the quality of the bone (Parfitt et al., 1987; van der Linden et al., 2001). Bone 
remodeling occurs, in part, to deal with loading. Loss of trabecular volume by resorption 
pits, thinning, or total loss of the struts will transfer loads and strains to the surrounding 
trabeculae (van der Linden et al., 2001). This could then result in elevating the frequency 
of bone resorption and bone loss in the compromised and surrounding trabeculae.  
Increasing stress surrounding resorption pits may also stimulate excess remodeling 
(and loss of trabeculae) due to targeted repair of microdamage.  An increase in strain at 
areas of stress concentrations can result in remodeling of the bone in order to distribute 
mass to best deal with loading (McNamara and Prendergast, 2005). This elevation of 
stress can induce microdamage, which seems to be targeted for remodeling and repair 
(Burr et al., 2003; Mashiba et al., 2000; Seeman and Delmas, 2006). Models suggest that 






lead to larger resorption pits, enhanced stress and microdamage, excess resorption, and 
ultimately disconnectivity of trabeculae (McNamara and Prendergast, 2005). 
 
2.1.7 Material Properties:  Matrix Minerals 
The mineral content of bone (primarily hydroxyapatite) resists compression very 
well, but poorly resists tension (Augat and Schorlemmer, 2006).  In fact, the mineral 
content of bone as well as BMD are the greatest contributors to stiffness. Young’s 
modulus and strength of bone will increase with increasing mineralization (Bouxsein, 
2005). The degree to which bone can absorb energy, however, will vary with increasing 
mineral content depending on the initial state of the bone: toughness will increase if the 
initial state was hypomineralized and decrease if already completely mineralized. Size of 
the mineral crystals is also important in determining material properties. As secondary 
mineralization occurs, the number and size of crystals increase (Augat and Schorlemmer, 
2006). Increased crystal size and crystallinity is associated with a trend for increasing 
brittleness. The number of microcracks can increase as the enlargement of crystal size 
negatively impacts deformation to failure of the bone (Davison et al., 2006).  
 
2.1.8 Material Properties:  Organic Matrix 
The organic matrix is a composite material composed mostly of type I collagen. Type 
I collagen permits flexibility and a partially elastic nature, and has a profound effect on 
bone toughness (Burr, 2002a; Davison et al., 2006; Wang et al., 2002).  However, 






bones of the body which consist primarily of cortical bone and experience significant 
tensile loading have collagen fibers that are typically oriented parallel to the long axis, 
adding to tensile strength and greatly increasing energy that must be absorbed to fracture 
the bone (Burr, 2002a; Skedros et al., 2006; Wang et al., 2002). However, variation of 
collagen fibril orientation does exist between lamellae within a bone and even within a 
single lamella (Figure 2.3A) (Currey, 2002).  Collagen fibers can also enhance bone’s 
toughness through fiber cross-linking. The decreased extent of collagen fiber crosslinking 
after skeletal maturity is associated with reduced toughness (Burr, 2002a; Davison et al., 
2006)  
 
2.1.9 Material Properties:  Microdamage 
Daily cyclical loading of forces below what is necessary to cause structural failure are 
imposed on the skeleton. However, fatigue damage from this loading can result in 
microcracks within the bone (Robling et al., 2006). The development of these 
microcracks can depend on loading regimes, as crack propagation occurs transverse to 
the direction of loading. These cracks are usually 30-100µm in length (Augat and 
Schorlemmer, 2006). Linear microcracks can originate at areas of stress concentration 
(such as lacunae and resorption cavities) during compressive loading. When induced by 
tension, the microcracks typically stay within the cement line, thus the bounderies of the 
osteons and lamellae can impede crack propagation (Davison et al., 2006). Crack 
formation may effectively dissipate energy. Increased loading, however, can lead to 






can lead to fracture (Davison et al., 2006; Robling et al., 2006). Microdamage, as 
previously mentioned, can be repaired by targeted remodelling (Burr et al., 2003; 
Mashiba et al., 2000). Increased porosity and the resulting reduced bone mass can reduce 
resistance to crack propagation by reducing fracture toughness, as the energy absorbing 
capacity of the remaining bone is reduced (Augat and Schorlemmer, 2006; Seeman and 
Delmas, 2006).  
 
2.1.10 Osteoporosis 
Osteoporosis is a condition in which bone resorption and formation are uncoupled, 
leading to excess resorption and ultimately bone loss (Lane, 2006). The clinical diagnosis 
of osteoporosis is made if a bone densitometry scan demonstrates a bone mineral density 
(BMD) that is 2.5 standard deviations below the mean peak bone mass of that of a young 
adult (Felsenberg and Boonen, 2005; Lane, 2006). The elevated turnover rate with 
excessive resorption reduces bone mass, as well as overall bone geometry, trabecular 
thickness, connectivity, cortical thickness, porosity, and mineral properties (including 
decreased mineralization and increased crystal size) (Davison et al., 2006; Gass and 
Dawson-Hughes, 2006; Harvey et al., 2006; Lane, 2006; Reginster and Burlet, 2006) 
(Figure 2.11). As such, osteoporosis is a disease characterized by increased bone fragility 
leading to an increased risk of fracture. Hip, vertebral, and distal forearm fractures are the 
greatest contributors to the estimated 1.5 million fractures related to bone fragility each 






exist as treatments for osteoporosis. These include bisphosphonates (antiresorptive) and 
intermittent administration of parathyroid hormone (PTH; anabolic). 
 
 
Figure 2.11.  Normal (A) and osteoporotic (B) trabecular bone. Note the porosity of 
the osteoporotic trabeculae in (B). Reproduced from (Martini, 2004). 
 
Bisphosphonates represent a class of pyrophosphate analogues that bind to the 
hydroxyapatite component of bone matrix (Coxon et al., 2006; Robey and Boskey, 2006). 
Osteoclasts can endocytose bisphosphonates during resorption, leading to apoptosis by 
inhibition of farnesyl diphosphate synthase, a key enzyme of the mevalonate pathway 
(Hirbe et al., 2006). As such, resorption is prevented and turnover is suppressed. Several 
bisphosphonates have been approved by the FDA for treatment of osteoporosis, including 






By reducing turnover bisphosphonates can increase BMD and strength. However, 
observations suggest that antiresorptives can decrease the risk of fracture greater than 
would be predicted by increasing BMD (Hernandez et al., 2006). A one-year treatment of 
bisphosphonates decreased fracture risk by 50-60% with only 5% increase in bone 
mineral density, providing evidence for a substantial role of different measures of bone 
quality on ultimate bone strength (Burr, 2004). Studies in osteoporotic patients have 
shown that bisphosphonates can preserve microarchitecture but may fail to restore 
damage to trabecular connectivity (Borah et al., 2004; Dufresne et al., 2003). An increase 
in mineralization can occur, elevating the stiffness of the bone and reducing the ultimate 
displacement of the bone (Bouxsein, 2005; Turner, 2002). But this can also increase 
brittleness (Davison et al., 2006). The work to failure tends to decrease with increasing 
mineralization – thus requiring less energy before failure, and increasing fragility. Also, 
by reducing the rate of remodeling, bisphosphonates can prevent repair of microcracks, 
decreasing toughness of the bone (Burr, 2002a) 
Parathyroid hormone (teriparatide, PTH 1-34) is an anabolic agent administered to 
reduce bone loss by stimulating new bone formation. In patients with osteoporosis, 
increased volume of trabecular bone, cortical thickness, connectivity (19%), and an 
increase in the proportion of trabecular plates have all been observed after intermittent 
PTH therapy (Jiang et al., 2003). In monkeys, bone formation has been shown to occur at 
the periosteal surface following treatment. At the same time, the increase in remodeling 
due to PTH also induces an increase in cortical porosity and partly counteracts the 






torsional and bending moments as a result of increased external diameter, more than 
compensates for the porosity, as porosity develops at the endocortical surface which 
experiences the least stress during bending (Ammann and Rizzoli, 2003; Burr et al., 
2001; Turner, 2002). In rabbits and rats, mechanical strength was increased or remained 
stable following intermittent PTH therapy, as formation of bone occurred on both 
endocortical and periosteal surface with increased porosity (Hirano et al., 1999; Lotinun 







2.2 The Generation of Reactive Oxygen Species Following Ionizing Radiation 
 
2.2.1 Ionizing Radiation 
Radiation therapy is an important method of treating cancer within the United States.  
Approximately 4 million new cases of cancer developed in 2006 (The American Cancer 
Society ) and approximately 50 percent of these patients will receive radiation therapy as 
a treatment for the disease (Bentzen, 2006). Radiation therapy has been an important tool 
in the ever-improving survival rates of cancer; estimated five year survival rates for 
breast, colon, and prostate cancer are 88.2%, 64.1%, and 99.8% respectively (The 
American Cancer Society #469). With improvements in radiotherapy and other treatment 
modalities, the population of cancer survivors has increased by more than 200% in the 30 
years prior to 2001 (Bentzen, 2006). Currently 62% of adults and greater than 75% of 
patients with pediatric cancers survive past five years (Robbins and Zhao, 2004). The 
effects of the radiation treatment on normal tissues will be the focus of this review, as 
atrophy in irradiated normal bone surrounding a tumor is the clinical concern leading to 
the investigations in this dissertation.  
Matter can absorb energy when exposed to sources of radiation, and it is the 
absorbance of this energy that imparts biologic effects within an organism (Hall, 2000). 
Two classifications of radiation sources typically considered are electromagnetic and 
particulate radiation. Electromagnetic radiation sources can include X-rays and gamma-
rays, both being composed of photons consisting of zero mass and no charge (Hall, 2000; 






(specifically the electrons), emitting a portion of the kinetic energy of the electron as a 
photon while ejecting an electron from its orbit. Gamma rays are produced as the energy 
discharged by the decay of an unstable nucleus (Hall, 2000; Turner, 1986). The 
wavelength of these forms of electromagnetic radiation are very short, measuring an 
estimated 10-8cm. Particulate radiation includes electrons (negative charge), protons 
(positive charge), or heavy particles. Heavy particles can be elemental nuclei with a 
positive charge due to absent electrons or uncharged, highly penetrating neutrons (Hall, 
2000). 
Ionizing radiation is radiation that has enough energy to remove electrons from atoms 
as it passes through a material. Photons will ionize atoms in cells and tissue in several 
ways. At lower energies, a photon can cause the ejection of a photoelectron when the 
entirety of the energy is absorbed by the atom, referred to as the photoelectric effect. 
Other photon interactions, namely inducing the scattering of an electron from an atom 
while releasing photons of lower wavelengths (Compton effect) as well as the production 
of electron pairs (electron and a positron), become more probable with increasing energy. 
Charged particles move through matter in a near linear path, losing energy in small 
quantities as energy is absorbed by electrons within the matter, causing direct ionization 
of the atoms (Turner, 1986). The ionization density, or the number of ion pairs that are 
formed along the length of the track (representing energy transfer per unit distance), is 
referred to as the linear energy transfer (LET), defined in keV/µm (Hall, 2000).    
Several factors are related to the impact of radiation on tissues. The units for absorbed 






will be Gray (Gy), 1 Joule per kg. The same dose of different types of radiation can have 
very different effects, depending on the LET, dose rate, and number of fractions (as well 
as radiosensitivity of the tissue) (Hall, 2000). For instance, the same absorbed dose of 
heavy ion radiation can have a much greater negative impact on tissues than that of low-
LET radiation such as photons (Hamilton et al., 2006). To help account for this difference 
in types of radiation, an equivalent dose, Sievert (Sv), is often used. The Sievert is 
defined as the absorbed dose multiplied by a weighting factor. The weighting factor for a 
particular type of radiation is the ratio of the biological effects of 1 Gy of 250 kV X-rays 
on a tissue (weighting factor of 1) relative to the biological effects of the particular 
radiation of interest (Hall, 2000).  
 
2.2.2 Ionizing Radiation and Reactive Oxygen Species Generation 
When photons or charged particles of high energy strike an atom, the molecules 
become excited.  Electrons are raised to higher energy levels and can ultimately become 
ejected, resulting in ionization (Hall, 2000; Riley, 1994). This process frequently occurs 
in water, resulting in the production of free radicals, defined as atoms, molecules, or 
compounds with one or more unpaired electron (Hall, 2000; Riley, 1994). The structure 
of molecular oxygen allows for the acceptance of electrons and ultimately the formation 
of partially reduced oxygen species, or reactive oxygen (or nitrogen) species, including 
peroxyl radicals (ROO*), alkoxyl radicals (RO*), and nitric oxide (NO*) (Riley, 1994). 
The hydroxyl radical (OH*) is the most reactive biologically and can induce the most 






also important reactive oxygen species in biological systems, although not as active as the 
hydroxyl radical (Robbins and Zhao, 2004). Hydrogen peroxide (the two electron 
reduction of oxygen) is a weaker oxidizing agent than superoxide. 
Formation of these reactive intermediates can occur in various ways. Approximately 
80% of the energy from ionizing radiation induces the loss of electrons from water. The 
following reactions are derived from Slupphaug et al. (Slupphaug et al., 2003) and Riley 
(Riley, 1994): 
H2O → H2O+     +   e-   
H2O+   +  H2O →    HO* +  H3O (formation of hydroxyl radical) 
OH*  +  OH*   →   H2O2 (formation of hydrogen peroxide) 
 
In the presence of oxygen, then, superoxide radicals will be formed: 
e-   +  O2  →  O2* - (formation of superoxide radical) 
 
Superoxide can react with protons to form hydrogen peroxide. The following process is 
referred to as dismutation:   
2O*2- + 2H+ →  O2 + H2O2 
 
A single electron reduction of hydrogen peroxide can occur to form the hydroxyl radical, 
thus hydrogen peroxide can serve as an intermediate for this more reactive radical: 







Reactive transition metals (like Fe) can serve as electron donors and form hydroxyl 
radical (OH*) by reacting with hydrogen peroxide (Courey et al., 1996; Robbins and 
Zhao, 2004; Vijayalaxmi et al., 2004).   
 
H2O2 + Fe2+ →  HO* +  Fe3+  +  OH- 
 
Most of these reactions occur very quickly, with the half life being from approximately 
10-6 to 10-10 seconds.  Superoxide and hydrogen peroxide are relatively more stable than 
the hydroxyl radical, perhaps persisting within water for 101 seconds and more than 102 
seconds, respectively (Robbins and Zhao, 2004; Vijayalaxmi et al., 2004).  
 
2.2.3 Ionizing Radiation and Cellular Damage 
Ionizing radiation induces cellular damage in several ways, particularly as a result of 
DNA interactions with reactive oxygen species. The damage, if unrepaired, can result in 
death of the cell, mutations, or induction of malignancy (Hall, 2000; Little et al., 2002). 
Directly, radiation that hits DNA can induce either single or double strand breaks (Hall, 
2000; Vijayalaxmi et al., 2004). Indirect damage to cells are due to reactive oxygen 
species, producing: single and double strand breaks in DNA; mutations; and impairing 
other cellular components, including organelles and membranes (Anscher et al., 2005; 
Bonner, 2003; Little et al., 2002; Riley, 1994; Rothkamm and Lobrich, 2003). The 
phosphodiester backbone of DNA can be attacked and cause single and double strand 






nucleotide most susceptible to damage via free radicals producing 8-hydroxy-
2deoxyguanosine (8-OHdG), and is a measure of carcinogenesis (Slupphaug et al., 2003; 
Vijayalaxmi et al., 2004). Additionally, DNA-DNA and DNA-protein crosslinks can 
form as a result of DNA damage (Prise et al., 2005).  
The damage to DNA due to ionizing radiation can have several impacts on the cell. 
The failure of repair mechanisms to rejoin DNA strands via homologous recombination 
or non-homologous end joining generally leads to cell killing when the cell enters mitosis 
(Hall, 2000; Prise et al., 2005). Thus mitotically active cells are sensitive to cell killing 
via radiation damage to DNA. Cell apoptosis can also occur by activation of the pro-
apoptotic gene p53 and the transcription factors AP1 and NF-kB due to double strand 
breaks (Habraken and Piette, 2006). Finally, mutations can result in oncogenic 
transformation, particularly if it occurs in genes regulating proliferation or apoptosis, 
such as the p53 (Prise et al., 2005). 
Macromolecules other than DNA can be damaged by free radicals produced after 
ionizing radiation. Free radicals can change the form and function of proteins. Damage to 
DNA binding proteins can alter levels of gene expression. Such damage could  
potentially change the expression of genes associated with preventing excess oxidative 
stress or induce apoptosis in the cell (Riley, 1994). Lipids are susceptible to damage by 
oxidative stress. Unsaturated sites on lipids react with free radicals causing lipid 
peroxidation and alters the membrane permeability of lipid membranes (Riley, 1994; 






cell, or cause leakage of destructive enzymes (i.e. lysozyme). Products of lipid 
peroxidation (e.g. 4-hydroxynonenal) can damage proteins and nucleic acids.   
Damage due to ionizing radiation and ROS can result in cell death. Yet the effects of 
ROS may not be limited to irradiated cells. Reactive oxygen species have been implicated 
in contributing to the bystander effect following ionizing radiation, in which irradiated 
cells (perhaps through gap junctions or extracellular secretions) communicate with non-
irradiated cells, and generate a response from that non-targeted cell or subsequent 
generations. Such responses can include enhanced genomic instability, sister chromatid 
exchange, signal transduction, and generation of micronuclei as well as generating an 
inflammatory response (Kadhim et al., 2004; Lorimore et al., 2001; Lorimore and 
Wright, 2003; Matsumoto et al., 2004; Morgan, 2003). Additionally, the state of 
oxidative stress can linger for several days after total-body irradiation, likely not a result 
of ROS produced as a result of the initial radiation exposure, but instead the propagation 
of these reactive intermediates (Robbins and Zhao, 2004).  
 
2.2.4 Physiological Presence and Function of ROS Within the Cell 
Outside of ROS generated as a result of stressors such as ionizing radiation, the 
presence and production of ROS within cells is normal. Superoxide is frequently 
generated within mitochondria as a result of leakage from the electron transport chain 
(Robbins and Zhao, 2004). Various enzymes also produce superoxide within the cell, 
especially from membrane-oxidases such as phagocytic nicotinamide adenine 






eliminated by the enzyme superoxide dismutase (SOD), producing hydrogen peroxide. 
Hydrogen peroxide is of particular note because it can diffuse across cell membranes and 
can generate other reactive species, such as the hydroxyl radical (Riley, 1994). In 
phagocytes such as neutrophils or macrophages, the production of ROS is an important 
component of the “respiratory burst” and used as a defense versus bacteria, and can also 
impact surrounding tissue by leaking outside of the cell (Nagata, 2005). In the neutrophil, 
hydrogen peroxide can be used to form hypochlorous acid (a very reactive ROS) within 
phagosomes due to the action of myloperoxidase (Robbins and Zhao).  
Reactive nitrogen species are also important components of cellular metabolism. 
Nitric oxide  (NO*) is formed from L-argenine by NO synthase, using an electron 
transfer from NADPH (Korhonen et al., 2005; Robbins and Zhao, 2004). Like 
superoxide, levels of NO* become elevated during inflammation.  Peroxynitrite (ONOO-) 
is metabolized from nitric oxide and superoxide by inducible nitric oxide synthase 
(iNOS), and serves a role in preventing infection, although in excess can cause DNA 
damage, cell apoptosis, necrosis, and tissue damage (Korhonen et al., 2005). 
Antioxidant enzymes function to remove oxidants from the cell, including superoxide 
dismutases (MnSOD in mitochondria, and CuZnSOD in cytoplasm), which convert 
superoxide to hydrogen peroxide (Riley, 1994; Slupphaug et al., 2003). Hydrogen 
peroxide can be removed and converted to water and O2 by catalase at high 
concentrations. Glutathoine peroxidase (GPx) catalyzes the conversion of H2O2 water and 
glutathione disulfide (GSSG) using glutathione (GSH) as an electron donor (Riley, 1994; 






reductase, and this requires NADPH to donate electrons. These antioxidant systems are 
vital to preventing ROS induced damage, yet the production of ROS within a cell as a 
result of irradiation is much less than is what is produced by normal cell metabolism 
(Bentzen, 2006; Robbins and Diz, 2006). However, as previously mentioned, 
concentration of ROS can remain elevated for days after irradiation. This provides 
evidence that radiation-induced changes in preservative antioxidant defenses may 







2.3 Establishing the Link Between Ionizing Radiation and Bone Damage  
 
2.3.1 High Radiation Doses Cause Bone Atrophy by Damaging Bone Cells and 
Vasculature  
Bone atrophy is a well-documented response of osseous tissue following exposure to 
the ionizing radiation characteristic of high-dose radiation therapy (Baxter et al., 2005a; 
Ergun and Howland, 1980; Howland, 1975). Reduction in bone mass and overall bone 
quality is dependent on several factors, including the dose absorbed, the energy of the 
radiation beam, the fraction size of the radiation dose, and the age and developmental 
stage of the patient (Mitchell and Logan, 1998; Overgaard, 1988). Osteopenia is often 
reported in patients one-year post-therapy, though the observed timing of reduced bone 
mass, overall loss of bone mineral density compared to controls, and changes in 
mineralization are variable (Hopewell, 2003; Mitchell and Logan, 1998). Despite this, 
demineralization of bone, thinning of bones, and loss of trabecular number has been 
described qualitatively following radiotherapy (Ergun and Howland, 1980; Hopewell, 
2003; Howland, 1975; Mitchell and Logan, 1998). Quantitatively, a significant (~30%) 
reduction in bone mineral density (BMD) was observed in patients with uterine cervix 
carcinoma using qCT from the 3rd lumbar vertebrae within 5 weeks after pelvic 
irradiation with either 45 Gy or 22.5 Gy total dose of high energy photons (Nishiyama et 
al., 1992). 
Bone loss following radiotherapy is thought to be a result of physiological changes 






1980; Gal et al., 2000; Hopewell, 2003; Huh et al., 2002; Konski and Sowers, 1996; 
Mitchell and Logan, 1998; Rohrer et al., 1979). The first report of radiation-mediated 
bone damage (termed “osteitis”) described a reduction in bone vasculature following 
obliterative endartitis and periartitis (Ewing, 1926). Early loss of vascularization occurs 
as a result of swelling and vacuolization of endothelial cells within the vascular channels 
of the osteons (Ergun and Howland, 1980; Hopewell, 2003; Rohrer et al., 1979). 
Ultimately, this results in the formation of sclerotic connective tissue within the marrow 
cavity. Fibrosis occurring in the sub-intima and replacement of vascular smooth muscle 
cells with hyaline-like material within the tunica media occur as late injuries, constricting 
the vessel lumen. Constriction of vascular lumen diameter within the periosteum, marrow 
cavity, and haversian system of rhesus monkey mandibles up to 6 months after exposure 
to 45 Gy total dose of gamma irradiation (cobalt-60) was a component of intimal fibrosis 
without changes in medial anatomy (Rohrer et al., 1979). The timing of the reduction of 
blood flow to bone seems dose-dependent. Rats exposed to a range of X-ray doses (5, 10, 
15, 20, 25 Gy at 250 kV) exhibited reduced blood flow to the femora at one month post-
irradiation following 20 Gy and 25 Gy exposure, yet blood flow was significantly 
reduced following all doses at 3 months (Pitkanen and Hopewell, 1983). Blood flow 
changes were more severe within the distal epiphysis than the shaft. A normal rate of 
blood flow returned for all groups except 25 Gy at 7 months; however, despite this 
restoration of blood flow, a reduction in bone mass (15-25 Gy) and mineralization (20-25 







Damage to bone cells (osteoblasts, osteocytes, and osteoclasts) is thought to be a 
primary contributor to reduced bone mineral density following irradiation (Bliss et al., 
1996; Ergun and Howland, 1980; Hopewell, 2003; Howland, 1975; Mitchell and Logan, 
1998; Sams, 1966b). A reduction in the overall number of bone-forming osteoblasts 
occurs following irradiation (Bliss et al., 1996; Ergun and Howland, 1980; Hopewell, 
2003; Howland, 1975). In primate models, osteoblasts and mesenchymal progenitors 
within the periosteum and marrow of mandibles were largely absent after 45 Gy total 
dose applied in fractions over 12 days, but evidence of remodeling (e.g. resorption pits) 
were still evident (Rohrer et al., 1979). Interestingly, in the few areas where osteoblasts 
and progenitors remained viable, the cells seemed to be proliferating with new osteoid 
being produced, forming exophytes. Normal vascular supply was found within these 
discreet areas despite widespread loss throughout the irradiated field. Likewise, a 
decrease in osteoblast numbers occurs within a day following high dose (> 15 Gy) 
gamma and carbon irradiation in rat models, remaining lower than non-irradiated controls 
for several months (Sawajiri et al., 2003). 
A decrease in osteoblast proliferation and both collagen and alkaline phosphatase 
generation following irradiation has been reported (Ergun and Howland, 1980; Gal et al., 
2000; Hopewell, 2003; Sams, 1966a). A reduction in the production of these markers 
indicates a loss of osteoblast function that lowers both the generation of mature bone 
matrix and impairs bone mineralization. In vitro cell culture studies of preosteoblasts 
(MC3T3 E1) have revealed a reduction in collagen production and proliferation 






proliferation in cultured preosteoblasts across a range of doses (0 – 60 Gy) also noted that 
even at high acute doses > 30Gy, direct cell killing was not induced (Szymczyk et al., 
2004). Rather, osteoblasts underwent cell cycle arrest and became more sensitive to 
proapoptotic agents (i.e., Ca2+Pi). Whatever the mechanism reducing osteoblast 
populations may be, the general accepted paradigm is that a greater reduction in the 
number and activity of osteoblasts relative to bone-resorbing osteoclasts results in a net 
loss of bone (Ergun and Howland, 1980).  
Osteocytes, which are responsible for the maintenance of mature bone, are thought be 
killed within irradiated bone following exposure to high doses (Ergun and Howland, 
1980; Mitchell and Logan, 1998; Rohrer et al., 1979). Osteocytes were shown to be killed 
within the irradiated field inside cortical lamellar and Haversian bone of 45Gy irradiated 
monkey mandibles, though were not affected within trabecular bone. However, 
osteocytes seem to be relatively radioresistant in several animal models. They remained 
viable for several months after a single 15 to 40 Gy application of irradiation in mice and 
rabbits (Jacobsson et al., 1987; Sams, 1966b; Sugimoto et al., 1991).   
The effect of irradiation on osteoclast health and function is unclear from the studies 
examining presence and activity from varied anatomical locations. Results from studies 
range from decreased osteclasts (Scheven et al., 1985), to stable numbers (Goblirsch et 
al., 2005; Vit et al., 2006), to data suggesting a transient, non-significant increase in 
osteclasts (Sawajiri et al., 2003) immediately after irradiation. Very high (30 Gy) acute 
doses of carbon and γ-radiation induced a very rapid (by 24 hours) decrease in osteoclast 






this investigation, no significant change in osteoclast numbers were apparent after 
exposure to doses of 15 and 22.5 carbon and γ-radiation until a sharp decline near day 5 
(Sawajiri et al., 2003).  However bone volume in the gamma-irradiated groups began to 
decline by day five post-irradiation, although all quantification was assessed via a 
histological analysis of a small fraction of the metaphysis (50µm2 area) (Sawajiri and 
Mizoe, 2003). By 12 weeks after irradiation from these animals, histological analyses of 
gamma-irradiated animals revealed large increases in fat within the marrow and virtually 
no trabeculae. Another investigation applying 25, 50, and 100 Gy X-rays to rabbit tibia 
resulted in significantly increased porosity within the primary spongiosa by the first 
histolgical examination at 4 weeks post-exposure, with no subsequent changes in porosity 
(Takahashi et al., 1994). This seems to indicate that the increase in resorption occurred 
prior to 4 weeks. Eight days after exposure to 20 Gy X-rays (40 Gy absorbed dose by the 
bone) osteoclast numbers within the distal femoral epiphysis of mice were unchanged 
relative to non-irradiated controls (Goblirsch et al., 2005). Likewise, both TRAP+ 
osteoclast numbers along the cortical bone of the humeral epiphysis in a mouse remain 
stable eight days following targeted 6 Gy X-ray irradiation, although ALP stained 
osteoblast numbers surrounding the proliferating growth plate were also unchanged 
relative to the control (Vit et al., 2006).    
Osteoblast progenitors in rabbit and mouse bone marrow were found to have been 
largely eliminated following acute exposures of 20 Gy X-rays and 50 Gy from a 14 MeV 
electron beam, respectively.  While bone formation was arrested, resorption was 






al., 1991). The bone formation within mice ceased for 9 weeks following exposure to 20 
Gy of X-rays, and in rabbits was decreased by 4 weeks with complete cessation at both 
12 and 24 weeks. Yet the reduction in bone formation was observed concurrently with 
massive bone atrophy and increased porosity within both animal models. Indeed, almost 
complete obliteration of the metaphyseal trabecular bone was observed in both the 
growing and nearly mature mice early post-irradiation (3 weeks and 5-6 weeks, 
respectively).  
 
2.3.2 Radiation Impairs Bone Growth 
The overall growth of bones in the body is impaired following irradiation 
(Brownstein et al., 2004; Eifel et al., 1995). Growth rate diminishes yet recovers 
following 4-5 Gy of irradiation, with permanent effects occurring at doses greater than 12 
Gy (Dawson, 1968; Sams, 1966b). Administration of a 14 Gy dose of radiation to a 
rodent will result in a massive, 85% reduction in growth rate, followed by an incomplete 
recovery at the cessation of puberty (Eifel and Sampson, 1991). Bone growth was found 
to completely stop in rodents following a single exposure to 20 Gy of radiation (Eifel and 
Sampson, 1991; Sams, 1966b).  
Reduced bone growth and density following radiation therapy for cancer is a concern 
for both patients and medical care providers. However, radiation-induced inhibition of 
bone growth and bone loss (3.4% of patients display osteoporosis 5 years after treatment) 
are still conditions associated with therapeutic radiation treatments (Gurney et al., 2003; 






limbs and bones can be observed several years after treatment. Several clinical studies of 
cancer survivors have indicated that total doses between 25 and 60 Gy can retard growth 
of skeletal elements, with the greatest reduction found at approximately 33 Gy (Eifel et 
al., 1995; Krasin et al., 2005; Mitchell and Logan, 1998; Probert and Parker, 1975). For 
instance, children with acute lymphoblastic leukemia, Hodgkins disease, musculoskeletal 
disorders such as rhabdomyosarcoma or central nervous system tumors like 
medulloblastoma, astroglioma, ependymoma, and nasopharyngeal carcinoma, receive 
high total doses of external radiation (in excess of 24 Gy), which can result in reduced 
long bone length (especially to bones within the irradiated field) and adult height 
(Brownstein et al., 2004; Darzy and Shalet, 2005; Eifel et al., 1995; Gleeson et al., 2003; 
Krasin et al., 2005; Mitchell and Logan, 1998). Moreover, doses on the order of 10-30 Gy 
can have a major impact on vertebrae, reducing the overall vertebral height (Mitchell and 
Logan, 1998).   
Since mitotically active cells are particularly sensitive to radiation, damage to the 
proliferative chondrocytes within the epiphyses of long bones contributes greatly to 
impaired skeletal growth. Mature long bones of the limbs (e.g. humerus, femur, and tibia) 
are created through endochondral ossification as a cartilage template forms during fetal 
development which will ultimately be replaced by bone. Linear growth of bones within 
the limbs occurs at the epiphyseal growth plates, which are bands of cartilage that include 
rapidly proliferating chondrocytes. This growth plate ossifies to form an epiphyseal line 
in mature bone. Proliferative chondrocytes are arranged in columns perpendicular to the 






1978; Roach et al., 2003; Silbermann and Kadar, 1977; van der Eerden et al., 2003). The 
rate of bone growth depends on the rate of chondrocyte proliferation and the height of the 
mature cell within the column. Exposure to ionizing radiation can damage these 
chondrocytes, or change the columnar arrangement of the proliferative cells, thus slowing 
growth (Horton et al., 2006; Sams, 1966b). Cartilage is an avascular tissue, relying on 
diffusion of gases from nearby vasculature. Any radiation-induced change in blood 
supply to the surrounding tissue can also damage cells within the growth plate. Radiation 
doses of < 1.8 Gy per fraction are typically used during cancer therapy to minimize the 
damage to epiphyseal cartilage (Eifel et al., 1995).  
Within a bone, disparity can exist between the growth rate at specific sites (i.e. distal 
vs proximal epiphysis; epiphysis vs diaphysis), such that radiation localized to one region 
can have a greater impact than at another. The epiphyses are generally more sensitive to 
radiation than the diaphysis (Eifel et al., 1995; Mitchell and Logan, 1998). Most growth 
of the humerus and tibia occurs in the proximal epiphysis, while for the femur, growth 
rate is highest in the distal epiphysis. Thus, placement of the knee or shoulder in the 
irradiated field can have a relatively high impact on limb bone length (Eifel et al., 1995; 
Mitchell and Logan, 1998). Bone growth at the periosteal surface seems to be impaired 
within the diaphysis, which can ultimately result in a reduction of shaft diameter 








2.3.3 Compounding Factors of Radiation-induced Reduction in Bone Growth and Bone 
Mineral Density  
The direct action of radiation on bone cells cannot entirely account for reduction in 
bone length and final height of the survivor. Radiation damage to the hypothalamic-
pituitary axis during cranial-only or cranial-spinal radiotherapy can result in growth 
 
 
Figure 2.12.  The cellular arrangement of chondrocytes and bone cells within the 
epiphyseal cartilage of a growing individual as well as the primary spongiosa (zone 






hormone deficiency (GHD), the most frequent endocrine disorder among childhood 
cancer survivors (Brownstein et al., 2004; Darzy and Shalet, 2005; Gleeson et al., 2003; 
Gurney et al., 2003; Odame et al., 2005; Schmiegelow et al., 2003). While a range of 
doses are indicated as thresholds for GHD following therapy (i.e. 24-36 Gy total dose), 
the majority of patients receiving total doses exceeding 27 Gy will have GHD as a result 
of damage to the hypothalamic-pituitary axis within 2-5 years of radiotherapy, although 
these changes can be observed after only 18 Gy application (Gleeson et al., 2003; Shalet 
et al., 1976; Xu et al., 2004).  
Additionally, chemotherapeutic agents such as methotrexate and mercaptopurine, and 
glucocorticoid therapies prescribed for cancers such as acute lymphoblastic leukemia 
(ALL) may contribute to the development of osteopenia (Davies et al., 2005; Hoorweg-
Nijman et al., 1999; Jenney and Levitt, 2002; Odame et al., 2005). Incidence of 
osteopenia during therapy is very common, with 83% of patients suffering from 
osteopenia in the lumbar spine within two years of therapy (Halton et al., 1996). 
Leukemic cells can themselves damage bone upon infiltration to the bone marrow and 
trabecular network. Impaired recovery of osteoblast progenitors can be observed 
following chemotherapy treatment (Davies et al., 2002). However, adult survivors 
frequently have lowered bone mineral density despite normal turnover, providing support 
to the hypothesis that a failure to achieve normal bone mineral density prior to skeletal 








2.3.4 Fractures Following Irradiation  
Impaired bone growth, osteopenia, osteoporosis, cell and vascular changes, and bone 
atrophy following irradiation can contribute to bone fractures in children and adults 
(Konski and Sowers, 1996; Moreno et al., 1999; Staatz et al., 2006). The effects of 
radiation on fractures are confounded by the increased risk associated with 
postmenopausal status and glucocorticoid treatment (Grigsby et al., 1995; Moreno et al., 
1999). High total doses of radiation, both acute and fractionated, can reduce the ultimate 
strength of irradiated bones (Baxter et al., 2005a; Hopewell, 2003; Nyaruba et al., 1998; 
Pitkanen and Hopewell, 1983). Pelvic bones absorb 60-70% of the total dose targeting 
nearby anal, prostate, or gynecologic tumors (Konski and Sowers, 1996; Moreno et al., 
1999). Insufficiency fractures of the sacrum, sacroiliac joint, pubis, ilium, acetabulum, 
femoral neck, knee, clavicle, humerus, ribs, and mandible are well documented in 
patients receiving radiotherapy (Bliss et al., 1996; Blomlie et al., 1996; Grigsby et al., 
1995; Howland, 1975; Huh et al., 2002; Moreno et al., 1999; Ogino et al., 2003; 
Overgaard, 1988). These fractures occur without significant trauma following atrophy 
and reduced elastic resistance. Approximately 3-6% of patients receiving radiotherapy 
will show symptoms of a pelvic fracture at some point following therapy, however, 
incidents in all patients (including asymptomatic individuals) has been estimated to be as 
high as 34% (Abe et al., 1992).  
The incidence of fracture seems to be correlated with fraction size. In one study, a 
significant proportion of patients experienced fractures after 1.8-2 Gy fractionated doses 






twice-daily 1.2 Gy fractions (Bolek et al., 1996). Likewise, spontaneous rib fracture 
incidence is elevated in patients receiving high dose fractions compared with standard 
dose fractions (Hirbe et al., 2006; Overgaard, 1988; Pierce et al., 1992). Risk of rib 
fracture has been reported from these reports to be approximately 1.8% (Pierce et al., 
1992). Palliative care radiotherapy is often applied directly to bones as an effective means 
to reduce bone pain for bone metastases:  50-80% of patients experience reduced pain, 
with estimates of approximately 30-60% achieving complete pain relief (Hartsell et al., 
2005; Sze et al., 2003). These doses are often administered in single fractions of 8-10 Gy 
or multifractions of 3-5 Gy, yielding a total of 20-30 Gy doses. However, incidence of 
pathological fracture has been shown to be higher following single-dose therapy than 
multifraction treatments, increasing fracture risk by 82%  (Sze et al., 2003). 
  Recently, Baxter et al reported that radiation therapy significantly increased the risk 
of pelvic fracture within a population of more than 6,000 women over the age of 65 
treated for anal, cervical, and rectal cancer (Baxter et al., 2005a). This increased 
likelihood of fracture within the irradiated group was elevated at all time points post-
treatment. Hip fractures accounted for approximately 90% of all pelvic fractures. Relative 
fracture risk was increased 66%, 65% and 216%, for cervical, rectal and anal cancers, 
respectively. These fractures result in substantial morbidity and mortality: nearly 20% of 
hip fracture patients will die within a year of injury (Baxter et al., 2005a; Lane, 2006). 
Mechanically, this may be in part due to reduced toughness of bone exposed to ionizing 






such, radiation clearly compromises bone health and can have a severe impact on the 
patient’s functional capabilities. 
Animal models of radiation injury have revealed that very high doses of irradiation 
can impact overall fracture strength of cortical bone (Nyaruba et al., 1998; Sugimoto et 
al., 1991). After exposure to a single 50 Gy dose, rabbit tibiae showed increased 
endosteal bone resorption by 4 weeks and increased intracortical porosity between 12 and 
52 weeks (Sugimoto et al., 1991). Sections of cortical bone from these irradiated 
proximal metaphysis showed reduced ultimate strength via three-point bending tests by 
12 weeks, with slight recovery by 52 weeks, coincident with the increase in porosity. 
Fractionation seems to have a profound effect on changes in fracture strength of the mid-
diaphysis of rat tibiae (Nyaruba et al., 1998). High doses of irradiation (40-60Gy) 
administered in 1.25 Gy twice-daily fractions resulted in no changes in maximal load to 
fracture, while single total dose application, or higher fractionated doses (2.5 Gy daily), 
reduced maximum load to fracture at 40 Gy and 60 Gy, respectively. These changes 
occurred despite no observed reduction in bone mineral content; however, it should be 
noted that 18 weeks following a single dose of 35 Gy, no change in fracture strength was 
reported in rat femora (Maeda et al., 1988).  
 
2.3.5 RANKL:  Primary Regulator of Bone Mass and Immune Function  
As previously noted, bone mass is a primary contributor to overall bone strength. 
(Ammann and Rizzoli, 2003; Heaney, 2003; Lane, 2006). The balance between the rate 






regulation of the number and the activity of cells involved in bone metabolism, namely 
osteoblasts and osteoclasts (Blair et al., 2006). Osteoblasts can regulate the 
differentiation and activity of osteoclasts, primarily through production of chemical 
messengers. Foremost among the cytokines inducing osteoclast formation are receptor 
activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG).  
RANKL, exists in both soluble and membranous forms. Membrane-bound RANKL is 
a member of the tumor necrosis factor superfamily, expressed on the osteoblast/stromal 
cell surface as well as by activated T cells (Hofbauer and Heufelder, 2001; Lacey et al., 
1998). RANKL binds to its receptor on the surface of osteoclasts and their precursors, 
stimulating osteoclast differentiation, activation, and inducing bone resorption (Lacey et 
al., 2000; Lacey et al., 1998; Suda et al., 2001; Suda et al., 1999; Takahashi et al., 1999). 
OPG, also a member of the tumor necrosis factor receptor superfamily, competes with 
RANK / RANKL binding as a soluble decoy receptor for RANKL, blocking the 
pathway (Kostenuik and Shalhoub, 2001; Simonet et al., 1997). Previous studies 
confirm this important role of the RANKL/OPG system: Transgenic mice 
overexpressing RANKL and OPG-knockout mice (OPG- / -) develop severe osteoporosis 
accompanied by increased osteoclast differentiation and activation, low bone-mineral 
density, and high bone turnover (Kostenuik and Shalhoub, 2001; Lacey et al., 1998; 
Mizuno et al., 2002).  
The RANKL / RANK / OPG signaling axis functions as an important mediator of the 
immune system in addition to directing skeletal homeostasis (Figure 2.13) (Clowes et al., 






cells capable of activating lymphocytes (T and B cells) after detecting foreign molecules 
(i.e., bacteria or viruses) and abnormal cells. Helper (CD4+) and cytotoxic (CD8+) T 
cells express RANKL as a surface molecule and in soluble form. RANK – RANKL 
binding between dendritic cells and T cells functions as a costimulatory signal, enhancing 
an initial activation signal that results in T-cell activation (Anderson et al., 1997; Josien et 
al., 1999; Park, 2005). Macrophages exposed to RANKL show increased survival, 
phagocytic activity, and the capability to activate T cells through antigen presentation 
(Park, 2005). Additionally, RANKL has been shown to enhance the role of the immune 
system by increasing proliferation and survival of T cells and inhibiting apoptosis in 
dendritic cells. The increased survival period for dendritic cells is directly proportional to 
the increased stimulation of T cell proliferation (Wong et al., 1997). Thus, RANKL 
enhances macrophage and dendritic cell-mediated T cell proliferation and activation. 
Furthermore, RANKL stimulates the production of proinflammatory cytokines from 
dendritic cells and T cells (Josien et al., 1999; Park, 2005). These cytokines, including 
TNFα, IL-1β and IL-6, serve to further mediate immune responses.  
 
2.3.6 T Cell Activation, RANKL, and Bone Loss  
Pathological bone loss is partially due to elevated RANKL production following 
inflammation and elevated T cell activation (Clowes et al., 2005; Takayanagi et al., 2000; 
Tanaka et al., 2005; Walsh et al., 2005; Weitzmann and Pacifici, 2005). The relatively 








Figure 2.13. The activity of the immune system (dendritic cells, activated T 
lymphocytes) and osteoblasts on osteoclast differentiation. Production of RANKL is 




relationship between bone metabolism and activity of the immune system (Arron and 
Choi, 2000). During certain pathological states, T cell activation is enhanced 
viainteractions between these lymphocytes and antigen presenting cells, such as dendritic 
cells or macrophages. RANKL production from activated T cells can help with the 
immune response, but also elevates osteoclast maturation, activity, and bone erosion. 
RANKL-induced bone loss is observed in conditions such as rheumatoid arthritis (Kong 
et al., 1999a; Stolina et al., 2003; Walsh et al., 2005), periodontis (Liu et al., 2003; 






(Hofbauer and Heufelder, 2001), and aseptic loosening of hip implants following the 
production of wear-particles (Masui et al., 2005). Mouse models of post-menopausal 
(estrogen deficiency) osteoporosis five-weeks after ovariectomy have increased 
CD3+/RANKL+  T cells in the bone marrow with increased indicators of bone resorption 
(e.g. resorption pits in bone, serum calcium), and decreased markers of bone formation 
(e.g. serum alkaline phosphatase activity) (Garcia-Perez et al., 2006). Other cytokines 
characteristic of inflammation and immune responses can enhance (TNFα, IL-1β, IL-6) 
and potentially inhibit (via IFNγ, though this cytokine can also promote 
osteoclastogenesis in vivo) the osteoclastic activity of RANKL, addressing the 
complexity of the relationship mediating immune and skeletal responses (Masui et al., 
2005; Takayanagi, 2005; Takayanagi et al., 2000).  
 
2.3.7 Reactive Oxygen Species, Cytokines, and Inflammation:  Causes of Pathological 
Bone Loss  
The production of reactive oxygen species within tissue and cells, as a result of both 
normal and pathological stressors can induce bone destruction by directly activating 
osteoclasts. Oxidants can lead to tissue damage and inflammation, and are also generated 
during these conditions (Anscher et al., 2005; Lean et al., 2005). Oxidative stress has 
been shown to increase osteoclast differentiation (Fraser et al., 1996; Lean et al., 2003; 
Suda et al., 1993). The administration of antioxidants such as glutathione, N-






resorption both in vitro and from in vivo murine studies (Ha et al., 2004; Kim et al., 2006; 
Lean et al., 2003)  
ROS also can contribute to bone loss during post-menopausal osteoporosis.  In 
addition to perhaps promoting osteoclastogenesis by upregulating expression of RANKL 
on T cells, a reduction in circulating estrogen can contribute to bone loss by reducing 
antioxidant defenses within bone cells (including superoxide dismutase, glutathione, 
glutathione reductase, and glutathione peroxidase), resulting in oxidant-induced 
osteoclast activation (Garcia-Perez et al., 2006; Ha et al., 2004; Jagger et al., 2005; Lean 
et al., 2003; Muthusami et al., 2005). Estrogen-deficiency-induced bone resorption is 
reversed in vivo by administration of NAC and mimicked by administration of an 
inhibitor of glutathione synthesis, L-buthionine-(S,R)-sulphoximine (BSO) (Jagger et al., 
2005; Lean et al., 2003). 
Oxidants act as second messengers within cells. Many of the intracellular molecular 
signals required for osteoclast differentiation, activation, and survival, including: NF-кB; 
c-Jun amino-terminal kinase (JNK); p38 mitogen-activated protein kinases (MAPKs) 
such as extracellular signal-regulated kinases (ERKs); and Akt are activated by oxidative 
stress (Bai et al., 2004; Ha et al., 2004; Lean et al., 2005; Nagata, 2005). RANK-RANKL 
binding results in an increase in ROS concentration within cells, particularly hydrogen 
peroxide (Ha et al., 2004; Kim et al., 2006). Antioxidants (i.e. NAC, glutathione, and α-
La) have been shown to reduce RANKL-induced elevation in intracellular ROS with 
subsequent impacts on signaling cascades. For example, these antioxidants inhibit the 






RANKL/TNFα, as well as blocking NF-кB-DNA binding (Ha et al., 2004; Kim et al., 
2006). Typically, osteoclasts are short-lived cells with survival prolonged due to 
RANKL-mediated activation of transcription factors such as Akt, which upregulates the 
antiapoptotic molecules of the Bcl-2 family and inhibits the apoptotic molecule Bad (Ha 
et al., 2004). ROS are required for RANKL activation of Akt. Additionally, oxidants 
produced following RANKL stimulation enhances formation of actin rings, structures 
required for the osteolytic function of osteoclasts (Ha et al., 2004).  
Hydrogen peroxide can also serve an autocrine or paracrine role in bone resorption. 
Activated osteoclasts and their precursors secrete hydrogen peroxide, which can activate 
surrounding osteoclasts upon diffusion through the cell membrane, particularly following 
stimulation with RANKL (Bax et al., 1992; Ha et al., 2004; Hall et al., 1995; Kim et al., 
2006; Lean et al., 2003; Lean et al., 2005; Steinbeck et al., 1998). The RANKL-induced 
increase in ROS are at least partially dependent on NADPH oxidase within osteoclasts 
(Kim et al., 2006). As previously noted, NADPH oxidase plays a critical role in the 
generation of ROS, especially during respiratory burst activity in phagocytes (Bokoch, 
1995; Forman and Torres, 2001; Forman and Torres, 2002).  Thus, hydrogen peroxide 
may serve as a local autocrine or paracrine factor, further enhancing the resorbing activity 
of ostoclasts in the surrounding tissue and leading to pronounced bone loss during 
conditions such as post-menopausal osteoporosis (Bax et al., 1992; Hall, 1994; 
Muthusami et al., 2005; Steinbeck et al., 1998).   
Cytokines also play vital roles in bone loss, particularly in combination with ROS. 






2005). Both hydrogen peroxide and superoxide stimulate RANKL production from 
osteoblasts and primary mouse bone marrow stromal cells. Proinflammatory cytokines 
such as TNFα, IL-1β, and IL-6 are active stimulators of bone resorption and characteristic 
of many inflammatory diseases leading to bone loss (Lam et al., 2000; Walsh and Choi, 
2003; Walsh et al., 2005; Wang et al., 2004; Weitzmann and Pacifici, 2005). Hydrogen 
peroxide can cause an increase in TNFα, IL-1, and IL-6 (Lean et al., 2005). These 
cytokines have been shown to induce osteoblast production of RANKL and to directly 
activate osteoclasts (Clowes et al., 2005; Walsh and Choi, 2003). TNFα is a strong 
promoter of osteoclastogenesis, even synergyistically acting together with small 
quantities of RANKL to promote osteoclast development in macrophages (Lam et al., 
2000). IL-1 and TNFα increase intracellular ROS, which elevate osteoclast survival and 
function by impacting molecular signaling pathways, such as NF-κB. (Roggia et al., 
2001; Sauer et al., 2001; Thannickal and Fanburg, 2000).  As extracellular calcium levels 
increase, expression of IL-6 and IL-6 receptor genes increases (Zaidi et al., 2003). As IL-
6 can prevent osteoclast recognition of extracellular calcium levels that otherwise would 
serve an inhibitory role in bone resorption, IL-6 can act as an autocrine and paracrine 
signal resulting in elevated bone resorption.  Increased levels of TNFα, IL-1β, IL-6 are 
also associated with post-menopausal osteoporosis, as estrogen normally suppresses 
expression of these cytokines (Clowes et al., 2005; Lean et al., 2003; Roggia et al., 2001).   
 Though the majority of studies examining the effects of reactive oxygen species on 
bone metabolism have reported increased osteoclast activation, survival, and function 






impaired by oxidants. Conditions of oxidative stress have been shown to inhibit 
osteoblast differentiation in mouse and rabbit osteoblasts and stromal cells (Bai et al., 
2004; Mody et al., 2001). Hydrogen peroxide leads to reduced alkaline phosphatase 
expression and production and type I collagen formation, both markers of bone 
formation. ROS were shown to inhibit phosphorylation of the transcription factor Runx2 
due to downstream effects on ERK and NF-кB activation. Runx2 controls expression of a 
variety of genes within the osteoblast, including osteocalcin, ALP, and type I collagen 
(Bai et al., 2004; Lian et al., 2004).  
 
2.3.8 Radiation, Inflammation, and Late Effects 
Inflammation and related normal tissue injury are characteristic of various tissues 
following exposure to ionizing radiation, and elevated inflammatory cytokine levels is an 
early yet sustained response of tissues to radiation (Hosoi et al., 2001; Robbins and Zhao, 
2004; Rubin et al., 1995; Van der Meeren et al., 2003; Yeoh et al., 2006). The response is 
characterized by the early activation of stress-sensitive kinases, proinflammatory 
transcription factors, and the upregulation and production of proinflammatory cytokines 
and chemokines, enhancing the attraction and activation of leukocytes. Elevated cytokine 
levels increase in both irradiated tissue and in circulating serum, contributing to the local 
and systemic inflammation observed after irradiation (Anscher et al., 2005; Rubin et al., 
1995; Van der Meeren et al., 2003). The increase in the production of proinflammatory 
and profibrotic cytokines is near immediate after tissue irradiation and includes IL-1α , 






2006; Ibuki and Goto, 1999; Liu, 2003; Narayanan et al., 1999; O'Brien-Ladner et al., 
1993; Rubin et al., 1995; Van der Meeren et al., 2003; Vujaskovic et al., 2001). 
Monocytes, macrophages, lymphocytes, fibroblasts, and endothelial cells have been 
observed to increase expression and production of these chemicals post-irradiation.  
The inflammatory response post-irradiation is also characterized by increases in cell 
adhesion molecules necessary for leukocyte arrest and extravasation of these cells into 
damaged tissue (Quarmby et al., 1999; Robbins et al., 1993). Leukocyte arrest within the 
vasculature of irradiated tissue and accumulation in the tissue is present in this tissue for 
weeks post exposure (Molla et al., 2003; Robbins et al., 1993). The expression of 
glycoproteins involved in slowing leukocytes by rolling prior to transmigration (E- and P-
Selectin) has been shown to increase after irradiation and by proinflammatory cytokines 
IL-1 and TNFα (Molla et al., 2001; Quarmby et al., 1999). P-selectin expression has been 
shown to increase on pulmonary vasculature within minutes following irradiation 
(Quarmby et al., 1999). An increase in ROS-mediated elevation in NF-κB activation 
following irradiation may play a role in the increased expression of E-selectin, as this 
transcription factor binds to the promoter region of the E-selectin gene (Hallahan et al., 
1995). Likewise, increasing the concentration of glutathione can decrease 
proinflammatory cytokines and chemokines (recruit leukocytes) produced from lung cells 
by reducing hydrogen peroxide-mediated activation of the transcription factors NF-κB 
and AP-1 (Rahman et al., 2005). Intercellular adhesion molecule 1 (ICAM1), an adhesion 
molecule involved in leukocyte arrest, will exhibit increased expression for several days 






Jaal and Dorr, 2005; Molla et al., 2003). Both IL-1 and ionizing radiation can cause 
endothelial cells to increase production of IL-8, a chemokine that can activate β2 
integrins on leukocytes (Gaugler et al., 2001; Quarmby et al., 1999). ICAM1 binds β2, 
assisting with arrest. Vascular cell adhesion molecule 1 (VCAM1) expression on 
endothelial cells is also expressed, binding to α4β1 integrin on circulating monocytes and 
neutrophils and are important in leukocyte recruitment into tissue at later time-points than 
ICAM1 following exposure (Molla et al., 2003). CD-31, a molecule important in the 
transmigration of leukocytes from vasculature into tissue, is likewise increased on 
irradiated endothelial cells following irradiation (Gaugler et al., 2001). Activated 
leukocytes within tissues will then produce ROS (Rahman et al., 2005). Taken together, 
an inflammatory response occurs following irradiation. 
The inflammatory response that occurs post-irradiation resembles a wound healing 
response. However, the response becomes ongoing, with waves of cytokines produced as 
a result of ongoing cell and tissue damage ultimately leading to tissue necrosis, fibrosis, 
atrophy, and vascular damage (Bentzen, 2006; Robbins and Diz, 2006; Robbins and 
Zhao, 2004; Stone et al., 2003).  These late effects are viewed in several organs and organ 
systems, including chronic renal failure, obstructive lung disease, idiopathic pulmonary 
fibrosis, fibrosis and tissue necrosis of the skin, demyelination of nervous structures, 
brain vascular damage, necrosis of white matter, and cognitive impairment (Anscher et 
al., 2005; Robbins and Zhao, 2004; Vujaskovic et al., 2001). Radiation-induced damage 
to microvasculature, endothelial cells, and increased numbers of activated macrophages 






(Vujaskovic et al., 2001). The observed hypoxia, increased proliferation and activity of 
macrophages, and profibrotic cytokine production from macrophages and fibroblasts 
resulted in lung fibrosis over a period of 6 months. Hypoxia itself can increase the 
cellular production of ROS (Vujaskovic et al., 2001). Chronic oxidative stress is 
associated with radiation-induced late tissue injury in several organs, including the 
kidney and lungs (Robbins and Zhao, 2004). The production of proinflammatory and 
profibrotic cytokines in irradiated tissues such as the lung as well as the presence and 
progression of late functional damage can be reduced by treatment with antioxidant 
enzymes (such as SOD) (Khan et al., 2003; Robbins and Zhao, 2004). Elevated hypoxic 
conditions, increased ROS, immune activation, and cytokine production following 
irradiation can thus interact to enhance cell death, and further tissue injury (Akmansu et 
al., 2005; Quarmby et al., 1999; Robbins and Zhao, 2004; Vujaskovic et al., 2001).  
Within the bone microenvironment, an inflammatory-type response involving 
increased macrophage activity and massive reduction in the number of hematopoietic 
cells within marrow has been documented from C57BL/6 mice very early after 4 Gy 
gamma irradiation (Lorimore et al., 2001). Phagocytic activity from macrophages was 
increased within bone marrow by 24 hours post-irradiation, as indicated by elevated 
membrane ruffling, lysosomal number and size, lysosomal acid β-galactosidase activity, 
and iNOS production coincident with a 74% reduction in tissue cellularity of the marrow. 
Although phagocytic clearing of the apoptotic marrow cells following irradiation is 
associated with this inflammatory response, neither apoptosis nor necrosis of tissue could 






clearance of the majority of apoptotic cells. Despite the cause of the increased phagocytic 
activity, the increase in activated macrophages and inflammation within bone after 
irradiation as well as physiological changes that occur as a result of irradiation (including 










CHAPTER 3:  INVESTIGATION OF BONE ARCHITECTURAL AND 
STRUCTURAL PROPERTIES IN SHIELDED HIND LIMB LONG BONES 
FROM RATS EXPOSED TO 56Fe26+ RADIATION 
 
3.1 Introduction 
Understanding health risks associated with exposure to the space environment has 
become a priority as plans develop for long-duration, manned exploration of the Moon 
and Mars. Astronauts face unique environmental conditions in space that have an impact 
on normal physiological processes and health. Numerous investigations have provided 
insight into the body’s response to microgravity and have documented the resultant 
muscle atrophy, cardiovascular effects, and immune system impacts, among others 
(Gridley et al., 2006; Smith et al., 2005; Tesch et al., 2005; Vazquez, 1998). Bone loss is 
observed in astronauts exposed to microgravity, particularly within skeletal support 
elements (i.e., lower extremities, pelvic girdle, or lumbar vertebrae) (Lang et al., 2004; 
Turner, 2000). Radiation exposure is another challenge of the space environment that will 
be faced during exploratory missions. During long voyages, astronauts will receive doses 
of ionizing radiation due to constant bombardment by high energy (E), high charge (Z) 
particles (HZE) of galactic cosmic rays. Intense bursts of protons released from the sun 
during solar particle events, such as solar flares and coronal mass ejections, will also 
contribute (Mortazavi et al., 2003; Todd, 2003). However, it is uncertain what role 






During missions outside the magnetosphere, astronauts will be exposed to charged-
particle species from all stable elements (H, He, C, O, and Fe are considered the most 
important) (Guida et al., 2005; Vazquez, 1998). Protons make up approximately 87% of 
the fluence of galactic cosmic radiation, which is present at an essentially constant, low 
dose rate approximately 100-fold greater than at the Earth’s surface (Durante and 
Kronenberg, 2005). Additionally, unpredictable solar particle events can deliver high 
doses of proton radiation: as much as 3 Gy over a period of hours to days (Townsend et 
al., 1991). However, the health risks from heavy-ion radiation may be even greater. High-
energy 56Fe26+ nuclei are of particular interest because their dense tracks of ionization 
result in high relative biological effectiveness, which is associated with concentrated, 
poorly repairable damage within organisms. Production of secondary fragments by 
56Fe26+ nuclei is also of concern (Brooks et al., 2001).  
Bone damage occurs following exposure to low linear energy transfer (LET) ionizing 
radiation (gamma and X-rays) and is thought to be a result of physiological changes that 
occur to both vasculature and bone cells, such as bone-forming osteoblasts and resorbing 
osteoclasts (Hopewell, 2003; Konski and Sowers, 1996; Mitchell and Logan, 1998). 
Previous studies suggest that osteoclast numbers remain unchanged in cultures of γ- and 
carbon-irradiated preosteoblasts cultured with normal bone marrow (Sawajiri et al., 
2006). Nevertheless, clinical studies have demonstrated an increased fracture risk 
following radiotherapy (Baxter et al., 2005a; Huh et al., 2002). The type and dose of 






exploration; therefore, it is unclear if these observations are applicable to the space 
environment. 
Although the effects of HZE radiation on bone health are relatively unknown, we 
recently identified profound loss of trabecular bone following whole-body exposure to 2 
Gy doses of iron (-34%), carbon (-39%), gamma (-29%), or proton (-35%) radiation 
(Hamilton et al., 2006). Despite the qualitative differences in these types of ionizing 
radiation, their detrimental effect on mouse bone health appears to be similar. These 
doses and types of radiation are relevant to space exploration and raise questions about 
the potentially substantial impact of radiation on astronaut bone health.  
The purpose of the present study was to quantify the long-term systemic effects of 
56Fe26+ radiation on bone architecture and turnover by excluding the hind limbs 
(particularly the tibiae) from whole-body irradiation. 56Fe26+ ions are among the most 
potent HZE particles present in the space environment and contribute disproportionately 
in terms of their numbers to significant health risks (Durante and Kronenberg, 2005). For 
that reason, we intend to quantify how various levels of 56Fe26+ irradiation affect bone 
physiology and microarchitecture in rats, which have greater bone mass than mice. Our 
primary objective was to conduct an observational comparison of bone 
histomorphometric parameters between shielded tibiae from irradiated rats and tibiae 









3.2 Materials and Methods 
 
3.2.1 Animals and Whole-Body Irradiation 
Forty 9-week old male Sprague-Dawley rats (Harlan; Indianapolis, Indiana) were 
shipped directly from the vendor to Brookhaven National Laboratory (BNL) and 
acclimatized for one week. All protocols were approved by the appropriate Institutional 
Animal Care and Use Committees at BNL and Loma Linda University (LLU). Rats were 
given access to food and water ad libitum and kept in a temperature-controlled (18-26°C) 
and light-controlled (12 hour light/dark cycle) environment. Thirty rats were randomly 
selected for radiation exposure (treatment groups), while ten control rats received no 
radiation. For irradiation, all rats were anesthetized using 1.5% isoflurane and placed 
supine in an acrylic chamber in which their head positions were established using a bite 
bar fixture. The chamber was mounted on a pre-aligned beam line fixture using fiducial 
pins. The beam dimensions for the Alternating Gradient Synchrotron (AGS) A-3 beam 
line were established by the 15.24 cm diameter beam pipe and upstream beam plug 
elements which served to collimate the beam to an approximately 15 cm wide by 14 cm 
high elliptical profile with a 0.5 cm concave lower shielded margin. This beam line used 
for AGS experiment 960 has been described (Zeitlin et al., 1998). The animals were 
centered vertically and placed horizontally such that the nose was a few millimeters from 
the right beam margin. The left beam margin was near the anterior femoral head such that 
all major internal organs were irradiated except the posterior gastrointestinal tract. The 
original experimental design had behavioral objectives and did not include bone 






exposure conditions were not optimized for the latter purpose. Kodak X-Omat X-ray 
films (Eastman Kodak; Rochester, NY) were placed behind the animals to define the 
irradiated portions of the body and to establish dose uniformity. The films were scanned 
with a clinical X-ray scanner along the animals’ long axis which established a spot width 
at this position of 14.3 cm (FWHM) and a dose uniformity of +/- 6%. At the edge of the 
field the intensity dropped to 10% of the plateau value over 8.4 mm and 5% over an 
additional 6 mm. The dose beyond 14.5 mm was 0 Gy (background levels); this includes 
the proximal tibia, the primary area of analysis. The proximal femur received 
approximately 5% of the central beam dose. These partial doses (10% and 5%) are made 
up scattered secondary particles of lower LET (not iron particles). They are generally 
small Z value particles, and having less momentum are more likely to scatter.  
The experiment was part of NASA-funded experimental collaboration BNL-9 in 
November 2002. The primary radiation was 5 GeV/μm 56Fe26+ ions delivered at dose rate 
of approximately 1.5 Gy/min as eighteen half-second spills per minute. The track 
averaged LET for the particles was approximately 143 keV/μm. It should be noted that 
for such high energy particles, scattered secondary electrons (delta rays) may have 
maximum ranges exceeding 1 cm which would contribute to the structure of the beam at 
its margin. Treated animals received 1, 2, and 4 Gy of radiation. Following irradiation, 
the rats were returned to their cages; no abnormal behaviors were observed during or 
after irradiation. Within 72 hours of irradiation, the rats (both treatment and controls) 
were shipped to LLU. The rats were humanely killed nine months after exposure. 






from analyses, thus reducing the number of samples in the study (0 Gy n = 8; 1 Gy n = 9; 
2 Gy n = 7; 4 Gy n = 7). Hind limbs were removed and fixed in a solution of 4% 
paraformaldehyde in 0.12 mM Millonig’s buffer (pH 7.3) and shipped to Clemson 
University. 
 
3.2.2 Serum Analyses 
Samples of whole blood were collected and serum was separated. Markers of bone 
turnover present in the serum were analyzed using a Toshiba Chemistry Autoanalyzer, 
including phosphorus, calcium, alkaline phosphatase (ALP) and tartrate-resistant acid 
phosphatase (TRAP). An ELISA (Biomedical Technologies Inc; Stoughton, MA) was 
performed to detect serum levels of the anabolic marker osteocalcin.  
 
3.2.3 Bone Architectural Analyses 
Architectural analyses were performed on right hind limbs: bones were cleaned of soft 
tissue, and the tibiae and femora were separated. Right femora were weighed and 
morphological data obtained. Tibiae were evaluated for trabecular microarchitecture and 
cortical parameters using microcomputed tomography (microCT, Scanco Medical; 
Bassersdorf, Switzerland), allowing cortical structure and trabecular microarchitecture to 
be imaged at 11 μm voxel size (Figure 3.1). To analyze the trabecular architecture, a 5 
mm section of bone distal to the proximal growth plate was selected for evaluation. 
Evaluation was performed on a total of 80 slices at identical locations within each tibia 







Figure 3.1. MicroCT images of the proximal tibiae from rat bones irradiated with 0 
Gy (A), 1 Gy (B), 2 Gy (C), and 4 Gy (D) 56Fe26+ radiation. The image is from a 
superior perspective (top of tibia) down through the tibial plateau toward the ankle. 
Scale bar is 1 mm. 
 
density (Conn.Dens) trabecular thickness (Tb.Th), trabecular number (Tb.N), and 










The diaphyses of these same tibiae were analyzed to examine cortical bone volume 
and porosity. Fifty slices from the shaft immediately proximal to the tibial-fibular 
junction were analyzed using the microCT to calculate volume, cortical porosity, and 
polar moment of inertia (pMOI). For polar moment of inertia, the Scanco software 
provided the principle moments of inertia for each chosen cross section (Ixx and Iyy). 
Polar moment was determined as the composites of these principle moments of inertia 
(Ixx + Iyy) for the many (infinite) neutral axes for a given cross section.  
 
3.2.4 Mineral Composition 
Compositional constituents of the femora and tibiae were assessed. Bones were 
weighed using a Mettler-Toledo scale (MT2, Mettler-Toledo; Greifensee, Switzerland) 
and then placed in an oven at 105°C for 24 hours to obtain a dry mass (Dry-M) and then 
ashed at 800°C for 24 hours to remove all the organic constituents. A final weight was 
used to obtain a mineral mass (Min-M). The percent mineralization (% Min) of the bones 
was calculated using the following formula: %Min = Min-M/Dry-M x 100 
 
3.2.5 Statistical Evaluation 
These data were tested for statistical significance using SAS/STAT software (SAS, 
Inc.; Cary, NC). Initial differences in bone histomorphometric indices and final analyses 
of serum and mineralization data were determined using one-way ANOVA, with a Tukey 






The stresses and strains imparted upon cortical and trabecular bone as a result of body 
mass through the lifespan of the rat will influence histomorphometric indices. Therefore, 
an analysis of covariance (ANCOVA) was performed in order to more appropriately 
comment on the effects of radiation dose on bone status by accounting for animal mass. 
Tukey’s post hoc analyses of ANCOVAs were performed to determine significant 
differences between groups. A P-value of < 0.05 was considered statistically significant. 
All data are presented as mean + standard error of the mean. 
 
3.3 Results 
3.3.1 Animal, Tibial, and Femoral Masses  
Animal mass for all treatment groups was less than control-group mass at 9 months 
post-irradiation (Table 3.1), though the difference for the 2 Gy group was not significant. 
Individual animals in the 1 Gy and 4 Gy groups were significantly smaller than control, 
having approximately 10% and 19% less mass, respectively (P < 0.001). At sacrifice, no 
differences were observed in tibial mass between groups. Femoral mass from only the 4 
Gy group was significantly different from control: The femoral mass from the 4 Gy group 
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3.3.2 Percent Mineralization 
The percent mineralization was calculated for a) the proximal epiphysis, diaphysis, 
and whole tibia, and b) the head, proximal epiphysis, diaphysis, and whole right femur 
from each rat. No changes were observed in the percent mineralization of any specific 
site within the bones or between the whole bones of the different groups. Only whole-
bone mineralization data are reported (Table 3.1).  
 
3.3.3 Trabecular Microarchitecture 
BV/TV within the proximal epiphysis were significantly less than the control in the 2 
and 4 Gy groups by approximately 20% (P < 0.05) and 26% (P < 0.01), respectively, 
when compared using ANOVA (Figure 3.2). The connectivity density of trabeculae 
within the epiphyses was also significantly reduced at these higher radiation levels 
(Figure 3.2). Conn.Dens, for each of the 2 and 4 Gy groups was 32% and 28% less than 
control, respectively (P < 0.05). Tb.Th. was significantly lower in the 4 Gy group then 
control and the 1 Gy group (P < 0.05). No differences were observed in Tb.N. or Tb.Sp. 
(3. 1, Figure 3.2). 
Significant radiation effects were reported for BV/TV, Conn.Dens., and Tb.Th. after 
testing the variables with an ANCOVA, which accounts for final animal mass (3.2). 
BV/TV was significantly lower in the 2 Gy group as compared with the control and 1 Gy 
groups (P < 0.05). Likewise, Conn.Dens. from 2 Gy individuals was significantly less  



























































































































Figure 3.2. Bone histomorphometric indices from the proximal tibiae of rats after 
56Fe26+ radiation. Panel A: Bone volume fraction (BV/TV); Panel B: Trabecular 
thickness (Tb.Th.); Panel C: Trabecular spacing (Tb.Sp.); Panel D: Connectivity 
density (Conn.Dens.); Panel E: Trabecular number (Tb.N.). Plotted values are 
means + standard error of the mean (SEM). Data were compared using a one-way 
ANOVA and a Tukey post hoc analysis to identify significant differences established 









other treatment groups (Table 3.1), and thus the lower BV/TV and Conn.Dens. relative to 
non-irradiated control remained significant despite accounting for final size of the 
individuals. After accounting for mass, no differences were observed in Tb.N. and Tb.Sp. 
However, Tb.Th. from the 4 Gy group is significantly less than all other groups even after 
adjusting for body mass (P < 0.05). 
 
3.3.4 Cortical Bone 
The diaphyses of the scanned tibiae were analyzed for changes in cortical parameters 
using absolute means (Table 3.1) and adjusting for final animal mass (Table 3.2). 
Comparing absolute means, the volume of cortical bone located approximately 0.5 mm 
proximal to the tibial-fibular junction was significantly decreased (P < 0.01) from the 
control in animals irradiated with 1 Gy (-9.5%) and 4 Gy (-8.1%) (P < 0.05). 56Fe 
radiation. PMOI was significantly smaller at this location in the 1 Gy (-19%, P < 0.01) 
and 4 Gy (-14%, P = 0.05) groups (Table 3.1). However all differences became 
insignificant when accounting for body mass (Table 3.2). Cortical porosity was 
unchanged in the irradiated diaphyses. 
 
3.3.5 Serum markers  
Table 3.3 summarizes the bone turnover markers from plasma. Tartrate Resistant Acid 
Phosphatase (TRAP), a biochemical indicator of bone resorption, was significantly 






were observed in the concentration of the other indicators of bone metabolism (i.e., 
alkaline phosphatase, osteocalcin, calcium, or phosphorus) in irradiated groups. 
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Table 3.3. Serum markers of bone resorption and formation in rats nine months 
after irradiation 
 
Notes: Mean + SEM. For comparisons of serum markers at control and 1, 2, and 4 Gy 





The present study reports that exposure to 56Fe26+ irradiation has a negative impact on 
bone microarchitecture and structure in rats even when hind limbs are excluded from the 
radiation beam. Compared to control, irradiated animals exhibited less BV/TV, Conn. 
Dens., and Tb.Th. after exposure to doses greater than 2 Gy. These changes in bone 
parameters were directly related to final animal body mass. Indicators of bone 
metabolism (mineral content, cortical porosity, serum protein analyses) were generally 
unchanged between groups, suggesting stabilized bone turnover at nine-months. 
Therefore the reduction in bone volume and impaired microarchitecture are likely 
permanent adaptations.  
By affecting trabecular bone volume and connectivity, higher doses (especially above 
2 Gy) of 56Fe26+ radiation have the potential to weaken trabecular microarchitecture, even 
in bones that are not directly exposed to radiation. The connectivity of the struts and the 
number and thickness of trabeculae can affect efficient transfer of forces throughout the 
 Control 1 Gy 2 Gy 4 Gy 
TRAP (U/L) 2.96 + 0.19 3.96 + 0.28 a 3.30 + 0.30  3.70  + 0.29  
Osteocalcin (ng/ml) 4.07 + 0.36 4.07 + 0.32 4.65 + 0.13 4.51  + 0.43 
Alkaline Phosphatase (µg/L) 137 + 13.0 156 + 10.5 170 + 13.3 168  + 19.2 
Calcium (mg/dL) 10.5 + 0.11 10.5 + 0.13 10.3 + 0.11 10.3  + 0.35 






bone. The greater the Conn. Dens., the shorter the length of the unsupported strut length 
within the trabecular lattice of the metaphysis. The strength of the trabecular bone strut is 
inversely proportional to the square of the unsupported length (Currey, 2002; Davison et 
al., 2006). Thus, by increasing the length of existing trabeculae through a reduction in 
connectivity, the critical buckling load can be reduced. 
Changes in cortical bone (including structural properties such as polar moment of 
inertia) occurred following irradiation. Although absolute cortical volume measurements 
decreased with increasing doses of 56Fe26+ radiation (within the 1 and 4 Gy groups), the 
observed differences in volume were no longer present when changes in mass were 
considered. Polar moment of inertia, a structural measure of resistance to torsion, is the 
composite of bending moment of inertia in a sample. The calculated values for pMOI are 
therefore concise methods of representing structural competency for torsional loads. This 
parameter is also therefore dependent on geometry of the bone (the amount and 
distribution of the bone within the area of interest), and has been shown to be directly 
related with body mass (Tommasini et al., 2005). Accordingly, the values for pMOI 
decreased following radiation treatments. Again, the significant differences were 
removed when adjusting values of PMOI for mass. 
Variation in final animal mass accounted for much of the observed variance in bone 
parameters (Table 3.2). Smaller animal mass presumably reduced skeletal loads on non-
irradiated bone and in accordance with Wolff’s Law, resulted in lesser volume of bone. 
Body mass is closely linked with health status of an animal. Several factors may have 






primary immune component of this study seems to indicate compromised health of these 
animals, such as kidney or liver dysfunction, indicated by decreased blood glucose, 
albumin, uric acid, and increased blood urea nitrogen (Manuscript Submitted). Impaired 
growth following irradiation could also account for these changes in bone, as the rats 
were ten weeks old at the time of irradiation and skeletal growth has been shown 
previously to slow until approximately sixteen weeks of age (Roach et al., 2003). It is 
known that irradiation impairs the overall growth of bones in the body (Brownstein et al., 
2004; Eifel et al., 1995), and radiation damage to the hypothalamic-pituitary axis can 
result in growth-hormone deficiency and reduced growth (Darzy and Shalet, 2005; 
Odame et al., 2005; Schmiegelow et al., 2003).  
Systemic factors produced as a result of tissue irradiation cannot be discounted as 
contributing to the observed bone atrophy. The reduction in mass alone did not account 
for the significantly smaller Tb.Th. in the 4 Gy group relative to control (Table 3.2). 
Elevated cytokine levels (including IL-1α , IL-1β, IL-6, TNF α) have been observed to 
increase in both irradiated tissue and in circulating serum, resulting in local and systemic 
inflammation (Akmansu et al., 2005; Anscher et al., 2005; Hosoi et al., 2001; Robbins 
and Zhao, 2004). Analysis of cytokine production from splenocytes cultured from these 
animals indicate that TNFα levels are elevated at levels approaching marginal 
significance nine months after 4 Gy irradiation (P = 0.056, Manuscript Submitted). TNFα 
is an active stimulator of bone resorption and is characteristic of many inflammatory 
diseases, leading to bone loss (Walsh et al., 2005; Weitzmann and Pacifici, 2005). As the 






at distant sites, including the tibia. TNFα levels are also associated with conditions of 
cachexia, which is characterized by weight loss due to abnormal catabolism of muscle, 
fat, and carbohydrates (Saini et al., 2006). Circulating TNFα could therefore influence 
body mass and bone metabolism directly, affecting bone volume in multiple ways. 
There is a paucity of studies that have examined the effects of particle radiation on 
bone quantity, quality, and turnover. Our previous investigations have revealed that direct 
exposure to photon, proton, and heavy ion radiation can significantly reduce bone volume 
and impair microarchitecture in a mouse animal model, as quantified via microCT 
(Hamilton et al., 2006). The loss of bone after HZE irradiation is in contrast with a 
histological investigation documenting an increase of BV/TV in the proximal tibia of 
weanling rats (irradiated at 3 weeks) after exposure to very high acute doses (>15 Gy) of 
carbon ions (Sawajiri and Mizoe, 2003). Other studies of 2-6 Gy carbon-irradiated pre-
osteoblasts co-cultured with bone marrow revealed that the osteoclast numbers tend to 
decrease versus non-irradiated cells (Sawajiri et al., 2006). Similarly, the concentration 
ratio of the Receptor Activator of NF-κB Ligand (RANKL) to osteoprotegrin (OPG) 
mRNA tended to decrease in these cultures. RANKL binds to its receptor (RANK) on 
osteoclasts and progenitors and serves as the primary stimulator of osteoclastogenesis and 
activity (Reddy, 2004). OPG is a soluble decoy receptor for RANKL. This could result in 
an increase in bone formation, although no significant differences from non-irradiated 
control were observed.  
Exposure of rodents to doses of 56Fe26+ radiation can result in reduced trabecular bone 






56Fe26+ ions. It is unclear if or how systemic factors influence the observed changes in 
bone. Thus, the mechanism and timing of any changes in bone after HZE irradiation 
remains poorly understood. Any insight into the effects of 56Fe26+ and particulate 
irradiation on bone may be important to the health of astronauts on future long-duration 
spaceflights (e.g., Mars) (Nelson, 2003). The link between health status, body mass, and 
bone needs to further investigated particularly at doses, dose rates, and energies modeling 
spaceflight scenarios. A thorough time-course investigation of changes in bone 
microarchitecture and structure following HZE irradiation will help clarify the 
mechanisms of bone loss as we prepare for exploratory space missions. Older, more 
mature animals are needed for study to properly identify direct or indirect impacts of 
HZE irradiation (or ionizing radiation in general) on bone tissue and cell metabolism, 







CHAPTER 4:  A MARROW ABLATING DOSE OF WHOLE-BODY RADIATION 
CAUSES A RAPID REDUCTION OF TRABECULAR BONE IN MICE 
 
4.1 Introduction  
Radiation therapy for cancer compromises the mechanical properties of bone 
contained within the treatment volume. Fractures of the pelvic bones, femoral neck, knee, 
clavicle, humerus, and ribs are well documented in cancer patients receiving ionizing 
radiation (Abe et al., 1992; Bliss et al., 1996; Howland, 1975; Huh et al., 2002; Pierce et 
al., 1992). Radiation-induced bone atrophy and reduced elastic resistance lead to 
fractures, even in the absence of a traumatic event (Grigsby et al., 1995; Moreno et al., 
1999). Indeed, Baxter et al. recently reported that radiation therapy significantly 
increased the relative risk of pelvic fracture (65-216%) within a population of more than 
6,000 women over the age of 65 treated for anal, cervical, and rectal cancer (Baxter et al., 
2005a). Hip fractures accounted for approximately 90% of all pelvic fractures. Within 
this demographic, these fractures can result in substantial morbidity and mortality; nearly 
20% of hip fracture patients will die within a year of the injury (Baxter et al., 2005a; 
Lane, 2006).  
The mechanisms leading to this increased likelihood of fracture after radiotherapy are 
unclear. Bone damage following radiotherapy is thought to be a result of physiological 
changes that occur in both the vasculature and osteoblasts (Dudziak et al., 2000; 
Hopewell, 2003; Sakurai et al., 2007). Vascular changes in bone have been observed 3 






radiation-induced reduction in the overall number of osteoblasts has been reported, which 
affects bone formation (Bliss et al., 1996; Ergun and Howland, 1980; Hopewell, 2003). In 
contrast, the effect of irradiation on osteoclasts is poorly understood. Osteoclast number 
and activity has been reported to remain stable or decrease after irradiation, while bone 
formation is reduced or arrested (Goblirsch et al., 2005; Sawajiri et al., 2003; Sugimoto et 
al., 1991).  
Among uterine cervix carcinoma patients, a significant (~30%) reduction in bone 
mineral density (BMD) has been observed using quantitative computed tomography 
(QCT) from the third lumbar vertebrae within five weeks of initiating pelvic irradiation 
(Nishiyama et al., 1992). Such a profound and acute loss of trabecular bone so early after 
exposure may indicate an increase in osteoclast activity, although a similar phenomenon 
has not been confirmed experimentally.  
Recently, we reported that exposure of mice to 2 Gy doses of both low- and high-
linear energy transfer (LET) radiation was associated with a significant reduction in 
trabecular bone volume fraction and connectivity four months after irradiation (Hamilton 
et al., 2006). Clinically, these doses are relevant in terms of daily fractions of radiation 
therapy applied to localized tumors. Larger single doses are often given for bone 
metastases for effective palliative care (Hartsell et al., 2005; Sze et al., 2003). These 
doses are often administered in single fractions of 8-10 Gy or multifractions of 3-5 Gy, 
yielding a total of 20-30 Gy doses. The analgesic mechanism for palliative-care 
irradiation is unclear, though inhibitory effects of osteoclasts within the irradiated field 






fracture is higher following high, single-dose palliative therapy than after fractionated 
treatments (Sze et al., 2003). Additionally, whole-body irradiation is administered to 
ablate marrow preceding bone marrow transplantation, and though not directly attributed 
to the irradiation component of this procedure, this population has a demonstrated decline 
in bone mineral density (BMD) after treatment (Schulte and Beelen, 2004). 
The purpose of this study was to quantify the effects of a single, whole-body, marrow 
ablating dose of 7 Gy γ-radiation on trabecular and cortical bone in mice. We investigated 
the structural properties of bone acutely after irradiation to determine if any observable 
changes in bone at this stage may provide insight into whether increased resorption is a 
cause for documented late radiation injuries, such as pathological atrophy and bone 
fracture. 
 
4.2 Materials and Methods 
4.2.1 Mice 
Nine-week-old female C57BL/6 (B6) mice (Charles River Breeding Labs; 
Wilmington, MA) were examined in this study. The animals were allowed an acclimation 
period of one week prior to irradiation; food and water were available ad libitum. The 
examination of bone was secondary to an immunological investigation performed at 
Loma Linda University (Loma Linda, CA); therefore, bone labels were not possible. 
Animal sacrifice was performed with 100% CO2 fourteen days after exposure. The 






examination of skeletal effects. The Institutional Animal Care and Use Committee of 
Loma Linda University Medical Center approved all procedures. 
 
4.2.2. Radiation Exposure 
Nine-week-old mice (n = 6) were exposed to total-body irradiation using 60Co-source 
gamma (γ) rays. A control group (n = 6) was not irradiated. Gamma irradiations were 
performed at the Loma Linda University Medical Center as previously described (Gridley 
et al., 2002; Gridley, 2001). A vertical beam from a retired AECL (Atomic Energy of 
Canada, Ltd.; Commercial Products Division; Ottawa, Canada) Eldorado therapy unit 
was employed. Prior to radiation exposure, non-anesthetized mice were placed into 
rectangular polystyrene containers with air holes (30 mm x 30 mm x 60 mm) as 
previously described (Gridley et al., 2002). Each mouse was irradiated with a single 7 Gy 
dose at a dose rate of ~0.7 Gy/min. Assuming an α/β ratio of three for bone, this dose 
represents a biologically equivalent dose (BED) of 20.3 Gy, and is the same to that used 
in human bone marrow ablation regimens (13.5 Gy total dose administered in 9 fractions; 
BED = 23.3) (Fowler, 1992). 
 
4.2.3 Bone Architectural Analyses 
Hind limbs were fixed in a solution of 10% formalin. After 48 h, the right hind limbs 
were placed in 70% ethanol. Architectural and histological analyses were performed on 






Prior to histological analyses, the right tibiae were evaluated for trabecular 
microarchitecture using microcomputed tomography (microCT 20, Scanco Medical AG; 
Bassersdorf, Switzerland), permitting the trabecular microarchitecture to be imaged using 
a 9 µm voxel size. An approximately 1 mm section of bone immediately distal to the 
proximal growth plate was scanned, and 3D images were reconstructed (Figure 4.1). 
Trabecular bone volume fraction (BV/TV), connectivity density (Conn.Dens.), trabecular 
thickness (Tb.Th), trabecular number (Tb.N), and trabecular spacing (Tb.Sp) were 
calculated for each sample. 
For cortical analyses, eighty slices of the tibial diaphysis were analyzed over a 
distance of 8 mm proximal to the tibial-fibular junction, with 100µm increment lengths 
between each slice. To determine cortical volume, traces were made at both the periosteal 
and endocortical surfaces. Intracortical porosity was also calculated for each sample by 
determining the percentage of the total volume of bone relative to the total volume of the 
area of interest.  
 
4.2.4 Histology and Histomorphometry 
Following microCT analysis, tibiae were decalcified in a weak formic acid solution 
(Immunocal™, Decal Chemical Corporation; Tallman, NY). Radiographs were made to 
assess the earliest time point of complete decalcification. Samples were embedded in 
paraffin and cut into sagittal sections 5 μm thick. Slides were examined prior to staining 
to identify landmarks consistent among bones, and these slides were then chosen for 







Figure 4.1. MicroCT image of (A) nonirradiated control and (B) 7-Gy irradiated 
bones. Images were reconstructed from slices obtained during analysis of the 
proximal tibia in mice two weeks after 7 Gy gamma-irradiation. The images extend 
approximately 1 mm distal from the growth plate. These images are oriented from a 




eosin (H&E), and then each was reanalyzed visually prior to histomorphometry to 
identify those samples containing the consistent landmarks among the different bones. 
Multinucleated osteoclast presence was determined by tartrate-resistant acid phosphatase 
staining (TRAP, EC3.1.3.2) of the paraffin sections using a commercial kit (Sigma; St. 
Louis, MO) and then counterstaining with hematoxylin. TRAP-stained slides were 
prepared from adjacent sections to support histomorphometric analyses of the H&E-
stained slides. Images of the growth plate were also systematically captured for 
qualitative evaluation. Micrographs were captured using a Zeiss AxioSkop 2 Plus 
microscope (Carl Zeiss Light Microscopy; Göttingen, Germany) and a Zeiss AxioCam 







Hallbergmoos, Germany). Quantitative histomorphometric analysis on the bone sections 
was performed using SigmaScan Pro software (SPSS; San Rafael, CA). 
Histomorphometric analyses were performed throughout the metaphysis, extending 
0.5 mm distal from the growth plate. Histomorphometric parameters presented follow 
standard definitions and nomenclature (Parfitt et al., 1987). The total length of trabecular 
bone within each metaphysis, or trabecular bone surface, was determined (BS, mm). Each 
subtype of surface was expressed as a proportion of total bone surface. These 
measurements along the trabeculae included the osteoclast surface (Oc.S/BS, %; 
percentage of bone surface covered by osteoclasts), eroded surface (ES/BS, %; 
percentage of bone surface containing Howship’s lacunae), and osteoblast surface 
(Ob.S/BS, %; percentage of bone surface containing cuboidal osteoblasts). The height of 
the cartilaginous growth plate was also measured. Mean growth plate height was 
determined for each bone by eighteen equidistant measurements taken parallel to the long 
axis of the tibia across the transverse length of the growth plate.  
 
4.2.5 Statistical Analysis 
All histomorphometric data were examined for statistical significance using 
SigmaStat Version 3.5 (Systat Software Inc.; Richmond, CA). A one-tailed Student’s t-
test was performed to reveal statistical differences between the control and irradiated 
groups. A P-value of less than 0.05 was considered a significant difference. All data are 








4.3.1 Animal Behavior 
No substantial qualitative behavioral differences were observed following irradiation. 
Irradiated animals exhibited a significant (~ 18%) reduction in body weight (P < 0.01, 
Table 4.1) compared with control mice two weeks postirradiation. 
 
 
Table 4.1. General bone, cortical microCT, and growth plate data from irradiated 













Notes: Abbreviations for bone volume fraction (BV/TV); connectivity density 
(Conn.Dens.); trabecular thickness (Tb.Th.); trabecular number (Tb. N); and trabecular 







 Control 7 Gy 
Animal Mass at Sacrifice (g) 20.6 + 0.5 16.9 + 1.0a 
Tibial Length (mm) 16.6 + 0.2 16.6 + 0.1 
BV/TV (%) 20.7 + 0.1 9.2 + 0.1b 
Conn. Dens. (1/mm3) 129 + 7 40 + 6b 
Tb.Th. (µm) 58.7 + 0.7 57.3 + 1.4 
Tb.N. (1/mm3) 4.56 + 0.05 3.35 + 0.09b 
Tb.Sp. (µm) 200 + 2.2 300 + 6.0b 
Cortical Volume (mm3) 5.81 + 0.05 5.73 + 0.05 
Cortical Porosity (%) 4.23 + 0.10 4.32 + 0.20 
Growth Plate Height (µm) 105 + 3 115 + 3 






4.3.2 Quantitiative MicroCT Analysis of Trabecular and Cortical Bone  
Absolute values for trabecular histomorphometric parameters are listed in Table 4.1. 
In the tibial samples scanned by microCT, irradiated bones exhibited significantly 
reduced BV/TV (-54%), Conn.Dens. (-69%), and Tb.N (-26%) compared with controls 
(all comparisons P < 0.001; Figure 4.2). Tb.Sp was significantly increased in the 
irradiated samples by approximately 49% (P < 0.001). No difference was observed in 
Tb.Th, cortical bone volume or porosity within the tibial diaphysis (Table 4.1). 
 
 
Figure 4.2.  Effects of 7 Gy γ-rays on bone microarchitectural parameters two weeks 
after irradiation, including (A) trabecular bone volume fraction (BV/TV); (B) 
connectivity density (Conn.Dens.); (C) trabecular number (Tb. N); and (D) 









4.3.3 Histology and Quantitative Histomorphometry 
Qualitative evaluation of micrographs identified several differences between 
histological samples from nonirradiated and irradiated bones (Figure 4.3). Trabecular 
struts extended longitudinally from the physis through the metaphysis in nonirradiated 
bones, whereas these lengthy struts were usually missing within the irradiated mice. 
Similarly, the hematopoietic tissue present within the marrow of the controls was almost 
entirely missing within the metaphysis of the irradiated bones. Tissue containing the 
morphological features of adipose tissue was present within the metaphysis in place of 
the normal marrow cellularity (Figure 4.3). 
In terms of bone anatomy and histology of the physis, the two groups shared some 
similarities. No difference was observed in bone length or total height of the growth plate 
between the irradiated and control bones (Table 4.1). Histologically, the physes within 
both groups contained a core of hyaline cartilage with overall decreased cellularity and 
irregular cartilage cell columns (Figure 4.3). For both groups, the columnar arrangement 
of the chondrocytes in the proliferative and hypertrophic zone cells was often largely lost. 
Hypertrophic zone cells were greatly reduced. Large expanses of acellular cartilage could 
be identified between the chondrocytes. A terminal bar of bone was present along the 
distal edge of the physes in both groups (Figure 4.3). 
 
4.3.4 Histomorphometry and TRAP Staining 
Histomorphometric analysis indicated a significant reduction in BS (P < 0.05) and no 







Figure 4.3. 100X images of H&E-stained proximal tibiae from control (A) and 7-Gy 
γ-irradiated (B) mice two-weeks after exposure. The arrows indicate bone present 


















Notes: Abbreviations represent total bone surface (BS) and parameters relative to BS 
including osteoclast surface (Oc.S); erosion surface (ES); and osteoblast surface (Ob.S). 
Mean + SEM. aP < 0.05 following t-test. 
 
 
osteoclasts and erosion surface were verified via TRAP staining and by validating the 
presence of TRAP+ osteoclasts within resorption pits (Figure 4.4). 
 
4.4 Discussion 
The findings of the present study demonstrate that a single dose of 7 Gy γ-radiation 
resulted in a rapid and substantial reduction of trabecular bone in mice. Several possible 
interpretations can be made regarding the nature of the observed reduction in bone 
following irradiation. Of these, radiation-induced reduction of bone growth, smaller body 
masses after irradiation, impaired bone formation, and increased resorption must be 
considered. While all of these can affect bone quantity and quality, an increase in 
resorption and osteoclast activity represent a novel possibility. Though these observations 
occurred in an animal model, early reduction in vBMD from radiotherapy patients as 
measured by QCT has also been shown to occur (Nishiyama et al., 1992), and patients  
 Control 7 Gy 
BS (mm) 5.00 + 0.50 3.25 + 0.34a 
Oc.S/BS (%) 3.40 + 1.36 2.40  + 0.96 
ES/BS (%) 7.9 + 1.8 12.5  + 2.2 
Ob.S/BS (%) 12.7 + 1.4 11.5  + 2.1 







Figure 4.4. 400X images following tartrate-resistant acid phosphatase (TRAP) 
staining within the proximal metaphysis from control (a) and 7 Gy irradiated (b) 
mice two-weeks after exposure. TRAP+ osteoclasts stain reddish-brown. Arrows 
indicate the presence of TRAP+ osteoclasts within resorption pits. Scale bars 










receiving whole-body, marrow ablating doses of radiation prior to bone marrow 
transplantation also have reduced BMD, as measured by traditional dual energy X-ray 
absorptiometry (DXA). An early increase in the resorption of bone following therapeutic 
irradiation and subsequent acute bone loss may be an important contributor to the 
increased fracture rates observed as late effects in radiotherapy patients. 
Reduced longitudinal bone growth with subsequent remodeling of the primary 
spongiosa due to chondrocyte damage alone cannot explain the extreme trabecular bone 
loss observed at such an early time-point after irradiation. The mice in this study were 9 
weeks old at the time of irradiation. The animals were not skeletally mature and were 
presumably still growing; complete maturation occurs prior to 6 months of age 
(Somerville et al., 2004). However, BV/TV within the proximal metaphysis of B6 mice 
normally reaches a maximum at 6 weeks of age and decreases until 24 months of age 
(Bouxsein, 2005; Halloran et al., 2002). Therefore, a cessation or reduction of 
longitudinal growth for two weeks might not translate into a reduction in BV/TV within 
this area.  
Additional histological analysis of the bones indicated that growth was at least slow 
within both groups at the time of sacrifice (Figure 4.4). In rodents, the cartilage within the 
growth plate remains into old age, although it can be effectively sealed by a transverse 
terminal bar of bone, thereby reducing additional growth (Martin et al., 2003; Roach et 
al., 2003). The terminal bar of bone has been described as a feature of aged rodents with 
reduced growth rate (Roach et al., 2003). This bar was present along the metaphyseal side 






control and irradiated tibiae, the cartilage exhibited several documented features of slow-
growing murine physes. For example, chondrocytes are typically organized within 
columns divided into zones arranged perpendicular to the growth plate; growth rate 
depends on the proliferation and the height of the mature cells within the column (Eifel et 
al., 1995). Moreover, decreased cellularity, widely scattered groups of cells, and 
irregular, short columns of chondrocytes separated by widened areas of hyaline cartilage 
within both groups provide evidence that growth was slow (Roach et al., 2003; 
Silbermann and Kadar, 1977). Finally, no difference was observed in growth plate height 
or tibial lengths between groups. Thus, we believe that growth was slow at the time of 
sacrifice. 
The smaller masses of the irradiated animals could contribute to the observed 
difference in bone between groups. Body mass and loading influence bone morphology 
in accordance with Wolff’s law (Currey, 2002). A reduction of mechanical stress on 
limbs results in bone loss, as evident in tail-suspension murine studies and during 
spaceflight (Judex et al., 2004; Lang et al., 2004; Sakai et al., 2002). The skeletal 
response to reduced loading in murine models is influenced by strain and site (Amblard et 
al., 2003; Judex et al., 2004). Although exact strain, age, duration of unloading, and site-
specific comparisons of previous tail-suspension studies and the current two-week 
irradiation study are unavailable, substantial bone loss has been observed from B6 hind 
limbs following unloading. Studies have documented approximately 40% less BV/TV 
from the proximal tibia of 8 week old B6 mice suspended for 1 week (Nakai et al., 2006), 






(Amblard et al., 2003) femoral metaphyses from 4 month old B6 suspended for 2 weeks. 
However, the limbs in this study were not unloaded: Final animal masses were 18% less 
than control after irradiation, but substantial loading of the hind limbs still occurred. 
Locomotor behavior was also similar between groups, as no marked change in behavior 
was observed. Reduced loading can also impact cortical porosity and volume, which were 
unchanged between groups. Therefore, the difference in body mass between groups 
cannot entirely account for the observed 54% less bone volume or degradation of 
trabecular connectivity. The effect of lower doses, which are less likely to cause reduced 
animal mass, should be studied at these early time points nonetheless.  
Any effect of radiation on osteoblast number and activity certainly could contribute to 
a reduction in bone volume following irradiation. A reduction in the overall number of 
osteoblasts and bone formation is generally accepted to occur following irradiation 
(Hopewell, 2003; Sawajiri et al., 2003). Absolute numbers of osteoblasts were observed 
to decline within the secondary spongiosa from this study as indicated by similar 
Ob.S./BS between groups despite significantly reduced BS in the irradiated groups (Table 
4.3). Formation rates could not be determined as the administration of flourochrome 
labels was not possible, and thus represents a limitation of this study. However, as 
previously stated, B6 mice achieve a peak BV/TV at approximately 6 weeks of age, 
therefore it would be unlikely for a reduction in bone formation to be largely responsible 
for the radiation-induced decline in trabecular volume fraction. It could, however, be a 






The magnitude of the difference in bone morphometric parameters between irradiated 
groups is substantial and occurred early after radiation exposure. As previously stated, 
such large differences are observed following conditions that induce osteoporosis, such as 
tail-suspension. The mechanism of bone loss during hind limb unloading is a 
combination of reduced bone formation and increased bone resorption (Bikle et al., 2003; 
Nakai et al., 2006). While we cannot firmly conclude that osteoclast activity was 
increased, more than half the BV/TV and nearly 69% of the connectivity was gone from 
the proximal metaphysis after two weeks. We believe this justifies exploring the 
possibility that bone resorption is elevated very early after irradiation.  
The effect of irradiation on osteoclast activity remains unclear. A dose-dependent 
decrease in osteoblast number has been reported to occur immediately within immature 
rat tibiae after high-dose (15-30 Gy) γ and carbon irradiation.  An increase in osteoclast 
numbers was discussed in this context, however no statistical evidence supported this 
evidence (Sawajiri et al., 2003). Other studies show no change in osteoclast numbers in 
culture after marrow was mixed with osteoblasts irradiated with 2-6 Gy gamma-radiation 
(Sawajiri et al., 2006).  To date no study has definitively shown an increase in osteoclast 
numbers after radiation. 
For this study, histological samples were examined for evidence that bone resorption 
was elevated at the time of sacrifice. TRAP staining identified the presence of osteoclasts 
by identifying TRAP+ multinucleated cells along the remaining trabeculae of both control 
and irradiated bones (Figure 4.4). No significant differences existed between Oc.S/BS or 






both groups were equivalent at the time of sacrifice. Since a large percentage of bone was 
lost (> 50%), we believe that the increased resorption was a very early response 
following irradiation and that osteoclastic resorption subsequently stabilized. These 
interpretations are made within the limits of histological analysis and without serum or 
protein analyses of bone resorption markers, which were unavailable due to the primary 
use of these mice in an immunological study as noted above.  
The observed differences from this study were limited to trabecular bone. There is a 
paucity of literature regarding radiation effects on cortical bone, and those that exist 
primarily focus on changes in bone strength. We also have observed a similar absence of 
cortical effects with multiple radiation types, but at lower doses than examined here 
(unpublished data, 2007). Studies in animal models indicate that very high doses of 
irradiation can affect overall fracture strength of cortical bone (Nyaruba et al., 1998; 
Sugimoto et al., 1991). After exposure to a single 50 Gy dose, rabbit tibiae showed 
increased endosteal bone resorption by 4 weeks and increased intracortical porosity by 12 
weeks (Sugimoto et al., 1991). Sections of cortical bone from the irradiated proximal 
metaphysis showed reduced ultimate strength via three-point bending tests by 12 weeks, 
with slight recovery by 53 weeks. In rat models, high total doses of radiation (40-60 Gy) 
applied to the tibia resulted in reduced ultimate strength by 24 weeks whether applied as 
an acute dose or as > 2.5 Gy daily fractions (Nyaruba et al., 1998). The effects of 
radiation on cortical bone generally appear to occur following much higher total doses 






One striking feature of our micrographs is the near total absence of hematopoietic 
cells within the metaphyses; tissue containing morphological features of adipose was 
present instead of normal marrow (Figure 4.3). The reduction in hematopoietic function 
and number is primarily caused by radiation-induced apoptosis among hematopoietic 
stem cells present within the marrow (Chen et al., 2006). An inflammatory-type radiation 
response involving increased numbers of activated macrophages and a reduction in the 
number of hematopoietic cells within tibial bone marrow of the metaphysis has been 
documented in C57BL/6 mice within 24 hours after 4 Gy γ-irradiation (Lorimore et al., 
2001). In fact, inflammation within tissue is a common early feature following 
irradiation, with elevated production of proinflammatory cytokines and reactive oxygen 
species (Bentzen, 2006; Stone et al., 2003). This process of increased phagocytosis within 
the marrow and inflammation and have the potential to initiate osteoclastogenesis and 
bone loss by production of proinflammatory cytokines and/or reactive oxygen species 
after irradiation. 
 
4.4.1 Study Limitations 
The constraints of this study were primarily due to the original immunological nature 
of the investigation. As previously mentioned, histological analysis and microCT results 
were the principal basis for inferring elevated resorption as causing the substantial bone 
deficits post-irradiation, as serum, protein analyses, and bone labels were unavailable 






feel the very large differences in bone (including histological and microCT data) 
observed at only two weeks after treatment substantiate our interpretations.  
In summary, an acute, whole-body dose of 7 Gy γ-rays induced substantial loss of 
trabecular quantity and microarchitecture at an early (14 day) time-point after exposure. 
A similar reduction in bone quantity may be associated with the increased risk of fracture 
that has been documented in humans receiving radiotherapy for various tumors. In 
contrast, no changes were observed in cortical bone. This study was designed to facilitate 
observations at what was thought to be at an early time-point after exposure, yet it is 
possible that resorption of metaphyseal trabecular bone (although perhaps stabilized at 
this point) was initiated much earlier. Further investigations, perhaps at time-points of 
hours to days, into the acute radiation response of osseous tissue is warranted to identify 

















CHAPTER 5:  INVESTIGATION OF OSTEOCLAST DIFFERENTIATION AND 
RESORPTION FROM MICE EXPOSED TO 2 GY X-RAYS 
 
5.1 Introduction 
Bone atrophy and increased risk of bone fracture is a well-documented response of 
osseous tissue following exposure to high-dose radiation therapy (Baxter et al., 2005a; 
Ergun and Howland, 1980). Bone loss following radiotherapy is thought to result from 
damage that occurs to bone vasculature as well as reduced proliferation and activity of 
bone-forming osteoblasts (Bliss et al., 1996; Gal et al., 2000; Hopewell, 2003; Huh et al., 
2002; Mitchell and Logan, 1998; Szymczyk et al., 2004). While atrophy is typically 
observed as a late effect, loss of bone mineral density (> 30% from the lumbar spine) 
after irradiation in cancer patients has been reported as early as five weeks post treatment 
(Nishiyama et al., 1992). Despite evidence that substantial bone loss can occur soon after 
irradiation, an increase in osteoclast activity following exposure has received little 
attention as a potential contributor to radiation-induced osteoporosis.  
The effect of radiation on osteoclast number and function are varied in published 
reports. Results range from decreased osteclasts (Scheven et al., 1985), to stable numbers 
(Goblirsch et al., 2005; Vit et al., 2006), to a non-quantitative description of a transient 
increase in osteclasts (Sawajiri et al., 2003) after irradiation. Reports of osteoclast 
numbers significantly elevated at several weeks after exposure use radiation in 
combination with another osteoclastogenic challenge (i.e., force applied to bone via an 






irradiation used as a single skeletal challenge, and has been quantified at early (2 week; 
Chapter 4) and late (4 month) (Hamilton et al., 2006) time points using microCT. 
Questions related to the direct effects of radiation on bone resorption and osteoclast 
number need to be addressed in order to reduce or prevent related bone atrophy.   
The purpose of this study is to examine osteoclast presence, number, and activity 
following an acute, whole-body dose of 2 Gy X-rays applied to mice. Since we have 
documented substantially less bone in mice two weeks after irradiation as compared with 
non-irradiated control, but shown evidence of stable resorption at that time, we will 
examine the response of osteoclasts and bone from marrow harvested at Day 1 (in vitro 
portion) and Day 3 (histology and microCT) after exposure. We hypothesize that 
radiation will induce an increase in osteoclast number and activity within the first few 
days after exposure  
 
5.2 Materials and Methods 
5.2.1 Mice 
Thirteen-week-old C57BL/6 (B6) mice (n = 24 total; 6 per group) were examined in 
this study (Charles River Breeding Labs; Wilmington, MA). The animals were allowed 
an acclimation period of one week prior to irradiation; food and water were available ad 
libitum. The Institutional Animal Care and Use Committee of Clemson University 









 While under anaesthesia (isoflourane), mice were exposed to single, 2 Gy total-body 
dose of irradiation using a Philips 150KV industrial portable X-ray unit. The 2 Gy dose 
was chosen based on results from a preliminary study using 2, 4, and 6 Gy-irradiated 
mice and comparing changes in bone two weeks after exposure. Significant reduction in 
bone architecture were observed following all doses; thus the lowest dose (2 Gy) was 
chosen. Additionally, single fractions of radiation used during radiotherapy are typically 
1.8-2 Gy. A total of 12 mice were irradiated. The dose was administered at 140 kVp with 
an exposure time of 1.46 min. Two groups (n = 6 each) were not irradiated.   
 
5.2.3 Bone Marrow Culture 
Two groups of mice (6 irradiated; 6 non-irradiated control) were examined for a cell 
culture study. Bone marrow cells were harvested from mouse femora one day after 
irradiation. The femora were removed from each mouse. Soft tissue was removed from 
each femur while under a sterile hood. The epiphyses were clipped off, and the marrow 
flushed out using a 5 mL syringe and 25 g 5/8” needle (WHO) with Alpha modified 
Eagle Medium (αMEM; Invitrogen; Carlsbad, CA) supplemented with 10% fetal bovine 
serum (FBS; Life Technolgies; Long Island, NY), 10 nM 1,25(OH)2 Vitamin D3 
(Calbiochem; LaJolla, CA), and 1% penicillin-streptomycin-Fungizone (Life 
Technologies). Marrow from two animals from the same treatment group was pooled in a 
sterile, tissue-culture polystyrene dish (Corning; Corning, NY). The cells and media were 






Cells were centrifuged for 10 min at 1200 rpm, resuspended in 1 mL of fresh αMEM 
supplemented with 10% FBS, 10 nM 1,25(OH)2 Vitamin D3, and 1% penicillin-
streptomycin-Fungizone. Cells were counted using a hemocytometer. Six million cells 
were seeded on one of two substrates (see below) and flooded with 1 ml fresh αMEM 
then incubated at a 37°C, humidified, 5% CO2/95% air environment.  
To quantify osteoclast number, cells were seeded on two-well Lab-Tek II chamber 
slides in triplicate for each sample (Electron Microscopy Sciences; Hatfield, PA) and 
inclubated for 14 days. To remove adherent cells other than osteoclasts, cells were 
incubated at 37°C with 5% CO2 for 5 minutes in 0.25% EDTA/Trypsin. Osteoclast 
presence was determined by tartrate-resistant acid phosphatase staining (TRAP, 
EC3.1.3.2) of the slides using a commercial kit (Sigma; St. Louis, MO) and then 
counterstaining with hematoxylin. All multinucleated, TRAP+ cells were counted within 
each chamber. 
To examine the resorptive capacity of the cultured osteoclasts, cells were seeded on 
hydroxyapatite discs (BD BiocoatTM OsteologicTM; San Jose, CA) in a 24-well plate in 
duplicate for each sample. At two weeks, disks were rinsed using deionized water and 1 
mL of bleach solution (6% NaOCl, 5% NaCl) was added to each disk at 37°C.  After a 
final wash, discs were allowed to air dry.  
Resorption pits were visualized via Von Kossa staining for mineralized bone. For the 
procedure, 1 mL of silver nitrate solution (5% AgNO3) was added to the wells containing 
a disk. The well plate was taken outdoors and exposed to sunlight for 1 hour. Disks were 






bicarbonate (5% NaHCO3) in 25% formalin solution for 1 minute, rinsed 3 times, and 
fixed using 1 mL of 5% nathiosulfate (HYPO) solution.  
Quantification of the number and area of the resorption pits was calculated from 
images captured using a 5X objective on a Zeiss AxioSkop 2 Plus microscope (Carl Zeiss 
Light Microscopy; Göttingen, Germany) and a Zeiss AxioCam HR digital camera with 
AxioVision 3.1 software (Carl Zeiss Vision GmbH; München-Hallbergmoos, Germany). 
Determination of the resorption pit size and number was quantified throughout the disk 
surface from images spliced together in SigmaScan Pro software (SPSS; San Rafael, CA) 
After splicing was complete, the white background surrounding each disk was filled 
using Photoshop 7.0.1 (Adobe Systems Incorporated; San Jose, CA). Images were 
opened again in SigmaScan, and the color was inverted. The threshold was set to match 
the resorption pit surfaces on the inverted color image. Very small pits were excluded 
from the analysis to avoid mistaking small artifacts on the surface of the disk with 
resorption surfaces: size of the excluded surfaces was previously determined from stained 
and unstained hydroxyapatite disks. All pits below an area of 100 µm2 were removed 
from analysis. Examination of stained and unstained HA disks revealed inconsistencies in 
staining along the outer perimeter of each disk. Therefore, the outermost portion of each 
disk was cropped using Photoshop in a consistent fashion, such that the total circular 
surface examined from each disk was 96.68 mm2. Total resorption area, resorption pit 








5.2.4 Blood Serum Analysis 
Blood serum concentration of TRAP5b was determined via ELISA using a 
commercially available kit (Quantikine; Minneapolis, MN) from animals sacrificed one-
day after exposure to provide additional evidence of overall osteoclast activity at this 
point. An ELISA was also performed using this serum to determine concentration of 
osteocalcin, a marker of osteoblast activity (Biomedical Technologies Inc; Stoughton, 
MA). 
 
5.2.5 Bone Architectural Analysis 
To examine the early post-irradiation presence and activity of osteoclasts within 
irradiated mouse bones, the other set of irradiated and control mice (n = 6 per group) 
were sacrificed on Day 3. Hind limbs were removed and tibiae were separated from 
femora. Soft tissue were removed from the tibiae then fixed in a solution of 10% 
formalin. After 48 hours, the hind limbs were placed in 70% ethanol. Prior to histological 
analyses, the right tibiae was evaluated for trabecular microarchitecture using 
microcomputed tomography (microCT 20, Scanco Medical AG; Bassersdorf, 
Switzerland), permitting the trabecular microarchitecture to be imaged using a 9 µm 
voxel size. An approximately 3 mm section of bone immediately distal to the proximal 
growth plate was scanned. Evaluation of the scans began 0.5 mm distal to the growth 
plate and extended 1 mm. Trabecular bone volume fraction (BV/TV), connectivity 
density (Conn.Dens.), trabecular thickness (Tb.Th), trabecular number (Tb.N), and 







Following microCT analysis, each tibia was decalcified in a weak formic acid 
solution (Immunocal™, Decal Chemical Corporation; Tallman, NY). Radiographs 
assessed the earliest time point of complete decalcification. Samples were embedded in 
both paraffin (left tibia) and resin (right tibia) and cut into sagittal sections 5 μm 
(paraffin) and 1.5 μm (resin) in thickness. Multinucleated osteoclast presence was 
determined by TRAP staining of the paraffin sections using a commercial kit (Sigma) and 
then counterstaining with hematoxylin.  
Histomorphometric analysis from captured micrographs was performed throughout 
the metaphysis, starting approximately 0.5 mm distal from the growth plate (in order to 
exclude the primary spongiosa) and extending 0.5 mm distal. Total trabecular bone 
surface (BS, µm) within each metaphysis was determined. Subsequent surface 
measurements were quantified relative to total bone surface. Osteoclast surface (Oc.S/BS; 
%), erosion surface (ES/BS; %), and osteoblast surface (Ob.S/BS; %) was also 
calculated.  
 
5.2.7 Statistical Analyses 
For the cell culture study, a repeated measures ANOVA was performed using SPSS 
Version 15.0 (SPSS Science Inc.; Chicago, IL) to examine any differences between 
irradiated and control groups, accounting for the replicate samples within each group. 
Serum and other histomorphometric analyses were examined for statistical significance 






Student’s t-test was performed to reveal statistical differences between the control and 
irradiated groups. A P-value of less than 0.05 was considered a significant difference. All 
data was presented as mean + standard error of the mean (SEM). 
 
5.3 Results 
5.3.1 In Vitro Osteoclast Number 
After one week of culture on chamber slides in osteoclastgenic media, the number of 
TRAP+, multinucleated osteoclasts was greater from irradiated marrow harvested one day 
after exposure then than from control animals (Figure 5.1; Table 5.1). No Within 
Replicate or Replicate*Group interactions were observed from any repeated measures 
ANOVA used for this study (Table 5.1). A significant Between Group effect was 
observed for osteoclast number. A mean increase of approximately 395% was observed 
from irradiated marrow relative to non-irradiated marrow (P < 0.05; Table 5.1).   
 
5.3.2 In Vitro Resorption 
The area of mineral resorbed on the HA disks after culture with irradiated marrow for 
2 weeks was significantly greater than when cultured with non-irradiated marrow (Figure 
5.2; Table 5.1). Total resorbed area was approximately 390% greater after irradiation (P 
< 0.05). The average area of each resorption pit was also significantly greater than 
control; irradiated pits were 78% larger than non-irradiated pits (P < 0.01). No group 








Figure 5.1.  Multinucleated, TRAP+ cells from marrow harvested one day after 2 
Gy whole-body irradiation from mice femora and cultured on chamber slides for 
one week.  TRAP+ cells appear reddish-browh, nuclei are counterstained with 
hemotoxylin. Arrows indicate multinucleated, TRAP+ cells. (A) Non-irradiated 
(control); (B) 2 Gy irradiated; (C) histogram comparing osteoclast numbers from 
non-irradiated (left) and irradiated (right) cultures.  Bars represent standard error 
of the mean. (*) P < 0.05 following repeated measures ANOVA comparing replicates 





























Figure 5.2.  Composite images of hydroxyapatite disks cultured for two weeks with 
(A) non-irradiated marrow and (B) 2 Gy irradiated marrow after harvesting the 
marrow from mice femora one day after exposure. White areas represent sites of 








Table 5.1.  Osteoclast numbers and resorption parameters from cells harvested 




Notes:  A repeated measures ANOVA was used to compare Between Group effects 
(control vs. 2 Gy irradiated) by analyzing data from each replicate for each of three 
samples within each group.  For osteoclast numbers, 3 replicates were perfomed for each 
sample within a group.  Resorption pit assays were performed in duplicate.  P values are 
for Between Group effects.  No significant differences (P > 0.05) were observed for 
Within Replicate or Replicate*Group interactions and are thus not listed. Significance 





5.3.3 Serum Chemistry 
Levels of TRAP5b in serum harvested one day after exposure (12.84 U/L + 0.52) were 
significantly increased relative to non-irradiated serum (8.53 U/L  + 0.52), representing 
an increase of approximately 50% over control (P < 0.01; Figure 5.3). No differences 
were observed in concentration of osteocalcin between irradiated (165 ng/mL + 13) and 
non-irradiated (169 ng/mL + 11) serum (P > 0.05).  
 
5.3.4 Microarchitecture 
The microachitecture and histological analyses were performed on irradiated tibiae 3 
days after exposure to 2 Gy X-rays. Relative to control, no significant changes were  
 Mean Control Mean 2 Gy P Value
Osteoclast number 322 + 30 1600 + 207 0.018 
Reorption pit number 294 + 86 350 + 156 0.080 
Total resorption pit area (µm) 101000 + 26700 413000 + 184000 0.043 
































































Figure 5.3.  Histograms comparing serum concentrations of (A) tartrate-resistant 
acid phosphatase (TRAP)5b and (B) osteocalcin from non-irradiated and 2 Gy 
whole-body irradiated mice one day after irradiation. (*) P < 0.01 following t-test. 
 
observed in any bone microachitectural parameters as quantified via microCT analysis 








Table 5.2. Histomorphometric parameters from mouse tibiae three-days after 










Notes: Abbreviations for bone volume fraction (BV/TV); connectivity density 
(Conn.Dens.); trabecular thickness (Tb.Th.); trabecular number (Tb. N); and trabecular 
spacing (Tb. S.); (BS) and parameters relative to BS including osteoclast surface (Oc.S); 
erosion surface (ES); and osteoblast surface (Ob.S).  Mean + SEM.  All P values > 0.05 




5.3.5 Histological Analysis 
TRAP stained sections of bone were used to identify osteoclasts within tibial metaphyses 
and quantify surface measurements (Figure 5.4). No significant differences were 
observed in BS between control and irradiated bones (P > 0.05; Table 5.2). Moreover, 
Ob.S/BS and ES/BS were unchanged between groups (Figure 5.4 and Table 5.2).  
However, a significantly greater Oc.S/BS was observed within the irradiated tibiae (P < 
0.001). The difference represents a 310% greater Oc.S/BS in irradiated bones.   
 
 Control 2 Gy 
BV/TV (%) 2.22 + 0.19 2.90 + 0.37 
Conn. Dens. (1/mm3) 3.16 + 0.78 3.45 + 0.53 
Tb.Th. (µm) 44.9 + 0.7 41.6 + 1.4 
Tb.N. (1/mm3) 2.06 + 0.13 2.06 + 0.13 
Tb.Sp. (µm) 515 + 33 498 + 33 
BS (mm) 6.26 + 0.57 5.69 + 0.33 
Oc.S/BS (%) 4.83 + 0.89 14.99 + 1.53 
ES/BS (%) 14.1 + 1.96 19.2 + 2.15 







Figure 5.4. 200X images following tartrate-resistant acid phosphatase (TRAP) 
staining within the proximal metaphysis from control (A) and 2 Gy irradiated (B) 
mice three-days after exposure. TRAP+ osteoclasts stain reddish-brown. Sections 
are stained to indicate the presence of reddish-TRAP+ osteoclasts along the 
trabecular surfaces (C) Histograms indicating the erosion surface (ES/BS), 
osteoclast surface (Oc.S), and osteoblast surface (Ob.S) as a percentage of total bone 
surface quantified within the trabecular metaphyses extending 0.5 mm distal to the 









































Osteoclast number and activity, and bone resorption, increase early following 
exposure to ionizing radiation from mouse marrow and within a mouse metaphysis. From 
marrow taken from the diaphysis of a long bone (femur) one day after exposure, 
osteoclast number is highly elevated by one week of culture, as is total mineral resorption 
after two weeks of culture (Table 5.2). TRAP5b levels were significantly increased in 
circulating serum one day after irradiation (Figure 5.3). These markers are indicators of 
bone metabolism (specifically resorption) within the mouse as a whole. Three days after 
exposure, the relative surface of trabecular bone within the tibia covered by osteoclasts (a 
proxy for osteoclast number) is also higly elevated over non-irradiated control (Table 
5.2). The stimulation of osteoclasts by ionizing radiation therefore has the capacity to 
induce resorption in vitro and in vivo. Early radiation-induced elevation of bone 
resorption (within the first week) may represent a cause of the reduced bone mineral 
density after exposure to therapeutic doses of radiation.  
In the bones harvested from mice three days after exposure, no differences were 
observed for BV/TV or other microarchitectural indices as determined by microCT 
analysis. Decreased BV/TV has been described in mice by 2 weeks after exposure to 7 
Gy γ-radiation (Chapter 4). Despite the reduction in BV/TV, surface measurements 
suggested stabilized osteoclast activity. In the present study, Oc.S was ~310% greater at 
three days.  The other indicator of resorption (ES/BS; or surface without an osteoclast but 
containing a Howship’s lacunae) was not elevated, as might be expected if resorption had 






significantly elevated serum levels of TRAP5b) therefore provide insight into the onset of 
increased osteoclast resorption within an irradiated bone, perhaps with appreciable and 
quantifiable bone loss within one particular bone occurring over the following days. 
Cells harvested from bone marrow one day after irradiation exhibited greater mineral 
resorption in vitro than from non irradiated cells, further support for elevated osteoclast 
activity after irradiation. Both total resorbed area and average resoption pit area were 
significantly elevated. However, the number of pits per HA disk were not different, but 
represent an increasing trend (P = 0.08; Table 5.1). It is possible that fusion of adjacent 
pits could account for this observation (Figure 5.2), reducing the number of pits per cell 
while increasing the average pit area. Therefore, the elevated total resorbed area per pit 
should be highlighted from this assay.  
Studies commenting on the presence and activity of osteoclasts within irradiated bone 
and culture examine effects at various timepoints, doses, sources of radiation, energies, 
and ages/strains of murine models. Not surprisingly, results have varied. One week after 
irradiating osteoblasts with 2,4, and 6 Gy γ and carbon radiation then culturing with non-
irradiated mouse bone marrow resulted in no change in osteoclast number relative to 
control  (Sawajiri et al., 2006). Eight days after exposure to 20 Gy X-rays (40 Gy 
absorbed dose by the bone) osteoclast numbers within the distal femoral epiphysis of 
mice were unchanged relative to non-irradiated controls (Goblirsch et al., 2005). 
Likewise, osteoclast numbers along the cortical bone of mouse humeri remain stable 
eight days following targeted 6 Gy X-ray irradiation (Vit et al., 2006). After a week of ex 






X-rays (200 kv) exhibited a decrease in osteoclast number and progenitor proliferation, 
but no change in number was observed in day 17 metatarsals from any dose up to 20 Gy 
(Scheven et al., 1985). Very high (30 Gy) acute doses of carbon and γ-radiation induced a 
very rapid (by 24 hours) decrease in osteoclast numbers in three week old rats (Sawajiri 
et al., 2003). In another study, application of 25, 50, and 100 Gy X-rays to rabbit tibia 
resulted in significantly increased porosity by the first histological examination at 4 
weeks post-exposure, with no subsequent changes in porosity (Takahashi et al., 1994). 
This seems to indicate that the increase in resorption occurred prior to 4 weeks. 
To date, this study represents the first definitive evidence of increased number and 
osteoclast number and activity following exposure to ionizing radiation and in the 
absence of other applied challenges (i.e., orthodontic force) (Tsay et al., 1999). Increased 
osteoclasts have been mentioned in papers that performed descriptional non-quantitative 
histological evaluation of irradiated weanling rat tibiae. (Furstman, 1972). Other studies 
that have discussed an increase in osteoclast numbers have done so in the context of non-
significant data from animals irradiated during periods of high growth rate (Sawajiri et 
al., 2003). From our studies of older mice (slower growing), we have documented 54% 
decrease in BV/TV and 69% decrease in trabecular connectivity within the tibial 
metaphysis two weeks after exposure to 7 Gy γ-radiation, but with histological evidence 
of stabilized resorption at this point. For the current study we report significantly elevated 
serum concentration of TRAP5b by Day 1, increased numbers of osteoclasts lining 
trabeculae by Day 3, and both elevated in vitro osteoclast number and resorption from 






respectively. Therefore, based on published histological observations of early changes in 
bone after irradiation as well as the results of this study and our previous investigations 
(Chapter 4), we propose that an acute and marked increase in osteoclast number and bone 
resorption occurs early (0-7 days) following radiation exposure. This initial increase in 
osteoclast number and resorptive capacity is transient. The resulting atrophy of skeletal 
elements and compromised bone microachitecture (at least in more mature individuals) is 
a lasting response. 
Several possibilities exist as to why an early and transient increase in osteoclast 
number and activity could translate into chronic osteoporosis. Early and late 
preosteoclasts within the marrow are thought to be relatively radioinsensitive (Sawajiri et 
al., 2003; Tsay et al., 1999). Somehow radiation may (through direct or indirect effects) 
induce osteoclast differentiation, proliferation, and ultimately create an osteoporotic state. 
The subsequent radiation-induced death of less differentiated osteoclast precursors (i.e., 
promonocytes or granulocyte-monocyte colony forming units) would result in reduced 
osteoclast number following the initial increase in osteoclasts (Sawajiri et al., 2003). 
Osteoblasts within the irradiated field are also negatively affected and can therefore 
prevent recovery via new bone formation. Ionizing radiation has been shown to reduce 
osteoblast proliferation, promote final differentiation, induce cell cycle arrest, increase 
sensitivity to apoptotic agents, and reduce collagen production (Dudziak et al., 2000; Gal 
et al., 2000; Hopewell, 2003; Sakurai et al., 2007; Szymczyk et al., 2004).  Arrested in 






Osteopenia and osteoporosis are chronic conditions that occur following radiation 
therapy targeting a tumor (Baxter et al., 2005a; Hopewell, 2003; Mitchell and Logan, 
1998; Nishiyama et al., 1992). Normal bone surrounding tumors will absorb some of the 
radiation dose. For instance, pelvic bones absorb 60-70% of the total dose targeting 
nearby anal, prostate, or gynecologic tumors (Konski and Sowers, 1996; Moreno et al., 
1999). Additionally, whole-body irradiation is administered to ablate marrow preceding 
bone marrow transplantation. Likewise, this population demonstrates osteoporosis and 
osteopenia after treatment (Schulte and Beelen, 2004). An early and acute increase in 
osteoclast activity could account for these conditions, in concert with confounding factors 
such as reduced osteoblast function and damaged vascularity. As such, the short term 
elevation of osteoclast number and activity may, with expansion of the model, prove to 
be a viable target to mitigate or prevent osteoporosis in bone following radiation therapy. 
In summary, we quantified increased osteoclast number during the first week 
following exposure to ionizing radiation. An associated increase in in vitro mineral 
resorption accompanies this increase in osteoclast number, as determined both in vivo and 
in vitro. If similar processes are occurring within normal bone present in an irradiated 
field during radiotherapy, this may account for the observed atrophy present in 
radiotherapy patients. Further work must identify if similar processes are occurring in 
bone using photons of energies employed during radiotherapy. Additionally, biological 
equivalent doses should be administered in order to determine if increased resorption is a 






CHAPTER 6:  VOLUMETRIC AND ARCHITECTURAL CHANGES IN BONE 
FOLLOWING CLINICALLY-MODELED RADIATION AND POTENTIAL 





Improvements in treatment, delivery and diagnosis have led to increases in the 
number of long-term cancer survivors (Robbins and Zhao, 2004). However, this has been 
accompanied by a growing population of long-term survivors at risk of developing 
deleterious effects in normal tissues resulting from the use of therapeutic radiation. 
Increased incidence of spontaneous hip fractures is demonstrated by patients receiving 
radiation to treat pelvic cancers, with incidents generally being documented between one 
to five years after therapy (Abe et al., 1992; Baxter et al., 2005b; Grigsby et al., 1995; 
Ogino et al., 2003). Atrophy of bone occurring as a result of exposure to ionizing 
radiation may represent a potential cause of this increased fracture risk. Osteopenia and 
osteoporosis are documented conditions among cancer patients receiving radiation, either 
as a means to reduce tumor size or to ablate marrow prior to stem cell transplantation 
(Baxter et al., 2005b; Hopewell, 2003; Nishiyama et al., 1992; Rodgers and Monroe, 
2007). We have recently identified an increase in osteoclast number along the 
metaphyseal trabeculae of tibiae three days after mice were exposed to 2 Gy whole-body 






after irradiation, cultures of marrow in osteoclastogenic media revealed an increase in 
osteoclast number (after one week of culture) and in vitro resorption (two weeks of 
culture). Single application of ionizing radiation has also resulted in a substantial 
reduction in bone volume fraction (BV/TV; ~54%) and trabecular connectivity 
(Conn.Dens.; ~69%) from mice tibiae two weeks after exposure to 7 Gy γ-radiation 
(Chapter 4). An increase in osteoclast number and activity in normal bone surrounding a 
tumor following exposure to radiation during treatment would represent a therapeutic 
target to prevent radiation-induced osteoporosis. Therefore, the observations of increased 
number and activity from irradiated mouse bones must be verified using animal models 
of different strains and species to establish a clear link between bone resorption and 
radiation. Specifically, these observations must be confirmed using equivalent doses and 
energies of photons (or protons) used clinically for treatment purposes. 
Bisphosphonates are a commonly used antiresorptive drug for treatment of 
osteoporosis and diseases of elevated bone turnover. These chemicals represent a class of 
pyrophosphate analogues that bind to the hydroxyapatite component of bone matrix 
(Coxon et al., 2006; Robey and Boskey, 2006). Osteoclasts can endocytose 
bisphosphonates during resorption, leading to inhibition of farnesyl diphosphate synthase, 
a key enzyme of the mevalonate pathway (Hirbe et al., 2006). The resulting disruption of 
proteins involved in osteoclast proliferation, cytoskeletal structure, and survival results in 
decreased osteoclast activity and apoptosis (Chapurlat and Delmas, 2006). As such, 
resorption is prevented and turnover is suppressed. Clinical use of these drugs has been 






trabecular thickness and connectivity), and decrease the risk of fracture at several skeletal 
sites (Benhamou, 2006; Borah et al., 2006; Kamel, 2007) 
The purpose of the study is to use a female rat model (higher bone density than mice) 
to identify and quantify any changes in bone at early time points after radiation exposure 
(two and four weeks). Our intent is to identify if atrophy and evidence of increased 
resorption is also observed using another rodent. In addition, a currently available 
osteoporosis therapy (the bisphosphonate risedronate) will be tested for its ability to 
reduce radiation-induced bone loss and alterations in trabecular microarchiture by 
decreasing osteoclast-mediated bone resorption. Our hypothesis is that bone loss 
following irradiation is a result of early osteoclast activation and increased turnover, and 
that treatment with an antiresorptive agent, such as risedronate, will reduce the extent of 
bone loss.  
  
6.2 Materials and Methods 
6.2.1 Rats and Groupings 
Twenty-week-old female Sprague Dawley rats were procured from Harlan (84 total). 
All protocols were approved by the appropriate Institutional Animal Care and Use 
Committees at Clemson University and Wake Forest University. The animals were 
acclimated at Wake Forest University School of Medicine (WFUSM) animal-care 
facilities for one-week prior to the initiation of the study. A total of 72 were selected for 
this study, with 12 extra procured to eliminate outliers by mass. At twenty one weeks of 






irradiated control + placebo (Control; n = 24); Irradiated + Placebo (Irr; n = 24); and 
Irradiated + risedronate (Irr + Ris; n = 24). Twelve rats from each treatment group were 
sacrificed at 2 and 4 weeks after the initiation of irradiation.  
 
6.2.2 Injections 
On Day 0 (Monday), rats received their first subcutaneous (dorsal midline) injection 
of either placebo (PBS) or bisphosphonate (risedronate; Procter and Gamble 
Pharmaceuticals; Cincinnati, OH) at a concentration of 0.04µg/kg/injection. Injections 
were given at the same time on each subsequent Monday, Wednesday, and Friday until 
the animals were euthanized. A total dose of 0.12 µg/kg of risedronate was thus delivered 
over the course of each week. 
 
6.2.3 Radiation Exposure 
Irradiation procedures were initiated on Day 1 (Tuesday). The right hind limb of 
animals receiving radiation (n = 48) were exposed to 4 Gy of 6 MV X-rays (while 
anesthetized using ketamine) using a linear accelerator (LINAC) in the WFUSM 
Department of Radiation Oncology. The control group was anesthetized but not exposed 
to X-rays. We are relying on the biological equivalent dose (BED) calculation, assuming 
an α/β ratio of 3 for both human and rat bone (Fowler, 1992). Treatment regimens for 
pelvic cancers commonly include administration of 30 x 1.8 Gy fractions (M-F for 6 
weeks) for a total dose of ~54 Gy to the tumor. Each hip receives 50% of each fraction 






exposure was therefore modeled by a total dose to the right hind limb of 16 Gy, given as 
4 fractions of 4 Gy each twice a week for two weeks (T,F/M,Th), resulting in a BED of 
36.8 (Fowler, 1992). The small difference in BED between human-hip and rat-limb 
exposure is within the error represented by the BED equation. Rats were transported back 
to Clemson University immediately following the final irradiation procedure. 
  
6.2.4 Bone Architectural Analysis 
At sacrifice, right and left hind limbs were removed and disarticulated. Tibiae were 
cleaned of soft tissue and fixed in a solution of 10% formalin. After 48 hours, the tibiae 
were placed in 70% ethanol. The femora were immediately frozen for future mechanical 
testing studies.  
The right tibiae were evaluated for trabecular microarchitecture using microcomputed 
tomography (microCT 20, Scanco Medical AG; Bassersdorf, Switzerland), permitting the 
trabecular microarchitecture to be imaged using a 9 µm voxel size. An approximately 3.5 
mm section of bone immediately distal to the proximal growth plate was scanned. 
Evaluation was performed starting 1 mm from the growth plate. A total of 227 slices (2.5 
mm) were traced and evaluated. Three dimensional images were reconstructed. 
Trabecular bone volume fraction (BV/TV), connectivity density (Conn.Dens.), trabecular 
thickness (Tb.Th), trabecular number (Tb.N), trabecular spacing (Tb.Sp), and trabecular 
structural model index (SMI, an unitless indicator of plate vs. rod shaped trabeculae - 
scores near 0 for parallel plate-like trabeculae, 3 for rods), were calculated for each 






6.2.5 Statistical Analyses 
All statistical analyses were performed using SigmaStat Version 3.5 (Systat Software 
Inc.; Richmond, CA). Correlation between body mass and time following irradiation was 
evaluated using a linear regression. Within each group, a paired t-test was performed in 
order to assess any differences in body mass between Day 0 and either Day 15 (Week 2 
group) or Day 29 (Week 4 rats). Tests to indicate between group differences from initial 
animal mass, animal mass at sacrifice, tibial lengths, and microarchitectural analyses 
were performed using one-way-ANOVA with a Tukey follow-up test (α = 0.05). Data are 
presented as mean + standard error of the mean (SEM). 
 
6.3 Results 
6.3.1 Animal Behavior, Masses, and Tibial Lengths 
No qualitative differences were noted in animal behavior between groups, either 
locomotor or diet, throughout the course of the study. All data for animal masses at the 
beginning of the study (Day 0) and at 2- and 4-week sacrifice timepoints are listed in 
Table 6.1. No significant differences were observed between any of the groups with 
regards to both mass on Day 0 (initial body mass) and animal mass at sacrifice (final 
body mass) (P > 0.05).  The initial and final mass for each individual rat was compared 
via paired t-test to determine if masses differed from the start to the end of the study: no 
differences were observed within any group (P > 0.05, Data not shown). A linear 
regression was performed within each group to determine if a change in body mass 






and 29.  Plots for the linear regressions as well as equations for each regression line are 
provided in Figures 6.1 and 6.2. No correlation existed between time and body mass: 
animal masses were unchanged within each group over the course of the study (P > 0.05). 
Tibial lengths at sacrifice were unchanged between all groups, comparing both 2 and 4 
Week data (P > 0.05; Table 6.1).  
Time (Days)































Figure 6.1. Plot of animal masses recorded for all the rats sacrificed at 2 weeks after 
the initiation of the study.  A linear regression was performed to identify a 
correlation between time and animal mass over 2 weeks.  No significant correlation 
was observed for any group (P > 0.05).  The equation for the regression line are as 
follows: Control y = 0.275x + 264;  Irradiated y = -0.07x + 258; Irradiated + 

















































Figure 6.2. Plot of animal masses recorded for all the rats sacrificed at 4 weeks after 
the initiation of the study.  A linear regression was performed to identify a 
correlation between time and animal mass over 2 weeks.  No significant correlation 
was observed for any group (P > 0.05).  The equation for the regression line are as 
follows: Control y = 0.275x + 264;  Irradiated y = -0.07x + 258; Irradiated + 
Risedronate -0.18x + 264. 
 
 
6.3.2 MicroCT Analysis: Week 2 
Bone volumetric and microarchitectural data are summarized in Table 6.2. BV/TV 
was significantly less for Irr compared with Control (-14%; P < 0.05) and Irr + Ris (-
17%; P < 0.01; Figure 6.3). Conn.Dens. was also significantly reduced for the Irr group 






group was also significantly reduced relative to Control (-22%; P < 0.01; Figure 6.4).  
Tb.Sp was significantly higher (P < 0.01) and Tb.N. was significantly lower (P < 0.01). 
  
 
Table 6.1. Body masses and tibial lengths during the course of the 4 week rat 
irradiation study 
 
Note: Group body masses and tibial lengths were compared using a one-way ANOVA, 
(α) = 0.05.  No statistical differences were present between body masses or tibial lengths.   
 
 
for the Irr group compared with Control (Table 6.2). No difference was observed for 
these parameters between Irr and Irr + Ris. While values for Tb.N and Tb.Sp. were not 
statistically different between Control and Irr + Ris animals, the non-significant data 
trend resembles the response of the Irr group (increase in Tb.Sp., P = 0.094; decrease in 
Tb.N, P = 0.057). SMI was significantly higher in the Irr group (1.31 + 0.11; P < 0.01; 
Table 6.2) as compared with the Irr + Ris (0.83 + 0.07). No difference in SMI existed 






2 Week Examination       
 Control 266 + 4 268 + 4 38.3 + 0.2
 Irradiated 265 + 4 261 + 4 38.5 + 0.1
 Irradiated + Risedronate 267 + 3 264 + 4 38.4 + 0.2
4 Week Examination     
 Control 264 + 3 267 + 4 38.7 + 0.2
 Irradiated 266 + 3 270 + 3 38.7 + 0.1






between Control (0.99 + 0.11) and Irr + Ris (Table 6.2). Tb.Th. from irradiated hind 
limbs was increased relative to Control, though significant only from the Irr + Ris group 
























Figure 6.3.  Histograms representing the mean bone volume fraction (BV/TV) for 
rats sacrificed at 2 Weeks (left set) and 4 Weeks (right set) after receiving no 
radiation (Control), 16 Gy fractionated radiation (Irr), or 16 Gy fractionated 
radiation and administration of risedronate (Irr + Ris).  Error bars represent 
standard error of the mean.  Means were compared using a one-way ANOVA.  (*) P 
< 0.05 versus Control; (+) P < 0.01 versus Irr + Ris; (#) P < 0.001 versus Irr + Ris.   
 
 
6.3.3 MicroCT Analysis: Week 4 
BV/TV was significantly elevated from drug-treated animals over Control (P < 0.01) 






than Control (P < 0.01), however by Week 4 no difference was observed between 
risedronate treated animals and Control (P > 0.05; Figure 6.4). Tb.N. from Irr rats 

































Figure 6.4.  Histograms representing the mean connectivity density (Conn.Dens.) for 
rats sacrificed at 2 Weeks (left set) and 4 Weeks (right set) after receiving no 
radiation (Control), 16 Gy fractionated radiation (Irr), or 16 Gy fractionated 
radiation and administration of risedronate (Irr + Ris).  Error bars represent 
standard error of the mean.  Means were compared using a one-way ANOVA.  (*) P 
< 0.05 versus Control; (+) P < 0.01 versus Irr + Ris; (#) P < 0.001 versus Control.     
 
 
The observation that Tb.N. and Tb.Sp. within the Irr + Ris were marginally different 






lower in the Irr + Ris group than the Irr  (P < 0.001) group, but by Week 4 was different 
than the Control group as well (P < 0.05). The same pattern for Tb.Th. from Week 2 was 
observed at Week 4: thicker trabeculae were present from Irr + Ris animals than Control 
animals (P < 0.001; Table 6.2). 
 
6.4 Discussion 
 Rat tibiae exposed to ionizing radiation at doses biologically equivalent to that which 
human hips receive during radiotherapy for pelvic cancer exhibited significant bone 
atrophy. Compromised bone volume and microarchitecture are evident by two weeks 
after exposure. Though some degree of recovery is evident by Week 4 (particularly 
reattainment of normal BV/TV), microarchitecture largely remains compromised (Tables 
6.2 and 6.3). The pattern of microarchitectural deterioration (i.e., decreased Tb.N., 
Conn.Dens, BV/TV, increased Tb.Sp and SMI) resembles the response of bone to 
conditions of increased bone resorption, such as ovariectomy-induced or postmenopausal 
osteoporosis (Benhamou, 2006; Borah et al., 2004). The difference in bone is unlikely 
caused by radiation-induced changes in body mass, growth of the limb, or behavior, as no 
differences in these parameters were observed between groups (Table 6.1 for mass and 
tibial length data). Previous results from our laboratory have identified an increase 
osteoclast number and activity within the first two weeks following exposure to ionizing 
radiation (Chapter 5). Therefore, an increase in osteoclastic resorption following modeled 
therapeutic radiation should be considered a potential cause of the radiation-induced 
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.  Superscripted a, b, and c represents significance versus control: a P < 0.05; b P 
< 0.01; c P < 0.001.  Superscripted d, e, and f represent significance versus irradiated only rats: d P < 0.05; e P < 0.01; f P < 




























































































































































The application of the bisphosphonate risedronate, an antiresorptive agent, provided 
sparing effects that were observed at both examined time points in this study and support 
the hypothesis that bone resorption is increased as a response to irradiation. Bone 
microarchitecture was damaged in rats receiving both radiation and risedronate, as 




Table 6.3.  Change in mean values for bone histomorphometric parameters relative 










increased in both treatment groups. However, BV/TV was unchanged relative to control, 
and the reductions in Conn.Dens. and Tb.N. were less than what occurred after radiation 
alone (Table 6.3). This provides evidence that application of risedronate blocked the 
increase in turnover to a limited degree relative to untreated rats. Risedronate was applied 
 Mean Change Relative to Control (%) 
Parameter Irradiated Only Irradiated + Risedronate 
 Week 2 Week 4 Week 2 Week 4 
BV/TV -14.2 -7.2 +3.7 +20.1 
Conn.Dens. -34.7 -14.7 -22.2 +4.9 
Tb.N. -13.6 -7.8 -8.3 +4.1 
Tb.Sp +21.9 +11.8 +11.9 +4.9 
SMI +32.9 +18.9 -15.4 -39.2 






one day prior to the initial irradiation. A lag in time over the course of the first two weeks 
perhaps occurred between the increase in resorption and the effectiveness of the drug. By 
week 4 the risedronate treated tibiae were fully recovered, as the increased BV/TV, 
Tb.Th, and more plate-like trabeculae (lower SMI) would not be considered 
compromised (Table 6.2). A shift toward lower SMI values (more rod-like trabeculae) 
indicate a compromise in trabecular structure (Borah et al., 2006), while more plate-like 
trabeculae would be more efficient in resisting bending moments (Stauber and Muller, 
2006). 
The results from this study are consistent with the effects of risedronate (and 
bisphosphonates in general) administered to prevent osteoporosis and reverse bone loss 
during conditions of elevated turnover (Rodan and Reszka, 2003). From longer-term 
animal studies, the resulting decrease in turnover due to bisphosphonate treatment has 
been shown to maintain trabecular integrity (Borah et al., 2002; Otomo et al., 2004). 
Likewise, bisphosphonates have been shown to effectively increase bone volume and 
maintain trabecular architecture in shorter term animal studies (~ 1 month) examining 
modeled conditions of increased turnover (Dalle Carbonare et al., 2007; Iwamoto et al., 
2006). For example, rats treated with high-dose glucocorticoids exhibit osteoporosis; 
risedronate administration decreases turnover and thus prevents this loss and increases 
BV/TV and TB.N relative to control (Iwamoto et al., 2006). Our results are similar to 
others documenting that suppression of turnover accounted for the bone-sparing effect of 
bisphosphonates. Thus, we assume our results demonstrate a risedronate-induced 






bisphosphonates is to induce osteoclast apoptosis and reduce bone resorption (Chapurlat 
and Delmas, 2006). By reducing osteoclast activity, bisphosphonates ultimately reduce 
bone formation as result of coupling, though delayed relative to osteoclast suppression 
(Rodan and Reszka, 2003). Future investigations must not only further identify the 
cellular and molecular response of cells within the marrow leading to osteoporosis after 
irradiation, but how antiresorptives affect each of these components. 
For both irradiated groups, Tb.Th was increased relative to Control by Week 2, 
though the elevation in the Irr group represented marginal significance (P = 0.067). By 
Week 4, values for Tb.Th. showed virtually no change in absolute terms or relative to 
Control, unlike the other histomorphometric parameters (Table 6.2 and 6.3). While 
administration of risedronate may explain the thicker trabeculae within that group, it 
would not explain this phenomenon within the Irr group. A decrease in trabecular 
thickness would be expected during states of elevated osteoclast activity, as resorption 
pits increase along the surface of trabeculae and ultimately perforate the struts while 
trabecular plates shift to rod-like structures (Ammann and Rizzoli, 2003; Felsenberg and 
Boonen, 2005).  
Examination of the struts from the individual slices on the microCT provides some 
indication as to the nature of these observations regarding Tb.Th. One interesting 
observation from this study is that an area lacking bone is present at near the same spatial 
location within the metaphysis of both irradiated groups (especially from the Irr group), 
and that this observation is pronounced at Week 4 (Figure 6.5). This area is an absence of 






consistently located “whole” generally seem thicker than other struts.  One may speculate 
that the Tb.Th. is actually elevated following irradiation as a compensatory mechanism to 
deal with bone loss throughout the center of the metaphyseal envelope, though no 
conclusive evidence is provided. If a change of strain distribution in the trabecular 
network surrounding the resorbed region resulted in higher strains experienced by these 
struts, a resulting increase in bone formation could produce thicker trabeculae (Robling et 
al., 2006). This may also provide a potential explanation as to the lack of a difference in 
BV/TV between irradiated and control animals at Week 4 despite decreased Conn.Dens.,  
Tb.N., and increased Tb.Sp. Determining a method to consistently analyze site-specific 
locations within metaphyses using conventional microCT or peripheral quantitative 
(qCT) should be employed in future studies to identify if increased resorption following 
irradiation occurs at preferential sites within the bone microenvironment.    
In general, trabeculae exhibited an unusual morphology from both irradiated groups 
in comparison with the long, parallel struts present within Control rats (Figure 6.5). 
Unusual trabeculae and areas of abnormal bone growth have been described from other 
studies examining irradiated bones (Rohrer et al., 1979; Sawajiri and Mizoe, 2003). 
These structures may be attributed to osteoblast activity. Ionizing radiation has been 
shown to affect osteoblasts in several manners, including: decrease proliferation; promote 
final differentiation; induce cell cycle arrest; and increase the likelihood of apoptosis 
(Dudziak et al., 2000; Gal et al., 2000; Hopewell, 2003; Sakurai et al., 2007; Szymczyk et 
al., 2004). However, active production of new osteoid and bone formation have been 






et al., 1979). It is possible that within an environment of increased osteoclast activity, 
surviving osteoblasts exhibit increased activity due to coupling. Despite the cause of the 
irregular struts, the increased thickness of these disconnected trabeculae would likely do 
very little to preserve the mechanical integrity of the structure.   





Figure 6.5.  Cross-sectional microCT images of rat tibiae.  The images are each 
taken from an identical location 1mm distal to the bottom edge of the growth plate.  







The radiation dosing regimen employed in this study modeled what a hip would 
receive during treatment for pelvic cancers. The risk of hip fracture is significantly 
elevated following radiotherapy (Baxter et al., 2005a). Therefore the bone loss after 
irradiation documented from this study allows some insight into a possible mechanism 
causing these fractures, and will be useful data for comparative purposes in future studies 
examining bone volume, microarchitecture, strength, and cellular response following 
clinically modeled irradiation. Similarly, the mitigating effects of risedronate in 
preventing microarchitectural deterioration after modeled radiation might prove to be a 
useful therapeutic tool in preventing these fractures, if future studies suggest any 
radiation-induced changes in strength are prevented as well. 
In summary, irradiated rat tibiae displayed reduced bone volume and compromised 
architecture by 2 weeks. Recovery of bone volume was evident by 4 weeks, though the 
remaining trabeculae had an unusual morphology with persistent decrease in Tb.N and 
Conn.Dens. Treatment with an antiresorptive mitigated much of the loss, although some 
microarchitectural deficits were present at 2 weeks. Recovery in the risedronate-treated 
animals could be observed by Week 4. These data support the hypothesis that radiation-
induced atrophy is due to elevation of bone resorption following irradiation. A greater 
effect was seen at week 2 than week 4, providing some insight into the time-course of 
loss. Future studies modeling doses the hip receives during cancer treatment must 
determine if these changes in architecture translate into reduced strength in order to 
assess if antiresorptive treatment should be considered an option to prevent atrophy and 






CHAPTER 7:  CONCLUSIONS AND RECOMMENDATIONS 
 
7.1 Conclusions 
The results from the studies included in this dissertation support the hypothesis that 
radiation increases osteoclast activity within bones, specifically rodent tibiae. This 
radiation-induced increase in bone resorption represents a new potential cause of the 
atrophy observed in bone following clinical irradiation, alongside reduced osteoblast 
numbers and damaged vasculature. This dissertation has quantified substantial bone 
atrophy in mice and rats two weeks after exposure to radiation doses modeling clinical 
regimens. Osteoclast number (in vivo and in vitro) and activity (in vitro) were increased 
within the first two weeks after exposure. Treatment with an antiresorptive agent 
(bisphosphonate) mitigated radiation-induced atrophy and loss of architecture, as would 
be expected if a radiation-induced increase in resorption was suppressed following the 
administration of the antiresorptive.  
The incidence of fractures is elevated among patients receiving cancer radiotherapy.  
These fractures result in substantial morbidity and mortality each year (Baxter et al., 
2005a; Lane, 2006). Survivorship among cancer patients is improving (Robbins and 
Zhao, 2004). The possibility exists that increased resorption after irradiation could result 
in this increased likelihood of fracture downstream from treatment. Therefore the 
findings of this dissertation are useful for future research in terms of identifying the 
nature of these fractures. 






7.1.1 Conclusions Chapter 3  
• Significantly reduced bone volume and compromised connectivity are observed within 
bones shielded from doses of iron radiation > 2Gy. The impaired microarchitecture, 
regardless of the cause, could translate into reduced mechanical strength (Keaveny et 
al., 2001). 
• A radiation-induced reduction in body mass is associated with this change in 
trabecular microarchitecture. A systemic (i.e., cytokine) cause of the observed atrophy 
after iron irradiation could not be assessed.   
• Markers of bone metabolism were similar in the shielded hind limbs of these rats by 
the sacrifice at nine months, suggesting that bone turnover was normal in the irradiated 
animals.   
 
7.1.2 Conclusions Chapter 4 
• Substantial bone loss occurs in mice tibiae two weeks after exposure to a dose of 
radiation (7 Gy γ-radiation). Bone atrophy after irradiation is well documented from 
bones examined months to years after irradiation, and typically considered a response 
due the the unavoidable damage to osteoblasts and vascularity (Ergun and Howland, 
1980; Hopewell, 2003; Mitchell and Logan, 1998; Sakurai et al., 2007). The degree of 
atrophy documented in this dissertation has never been quantified from other animal 
studies examining radiation and bone. Our results indicate a ~54% in BVTV and 






bone strength (Borah et al., 2002), thus these bones (especially with a 69% loss of 
connectivity) should be considered compromised.   
• The loss of bone volume and architectural indices from mouse tibiae after the single, 
high-dose gamma radiation (7 Gy) likely occurs prior to two weeks after exposure.  
Thus, bone loss occurs early following irradiation. The bone histomorphometric 
parameters indicating the state of bone metabolism (particularly ES/BS and Oc.S./BS) 
are similar between non-irradiated and irradiated tibiae at this time.   
 
7.1.3 Conclusions Chapter 5 
• Whole body exposure to ionizing radiation (2 Gy acute dose of X-rays) results in an 
increase in osteoclast number. This increase can be seen within mouse tibiae only 
three days after exposure. The difference represents an elevation of more than 300% 
between control and irradiated individuals. However, at this time point no difference 
in bone volume or microarchitectural indices is observed between groups as 
determined by microCT. Thus, while Oc.S/BS is highly elevated, resorption is likely 
being initiated near this time point.   
• Although bone volume or surface are similar between control and 2 Gy irradiated 
bones three days after irradiation, overall bone resorption is increased at day one.  
Serum TRAP5b levels are significantly elevated in irradiated animals at this early time 
point. Likely the processes observed within the proximal tibiae (increased Oc.S./BS) 
are occurring thoughout the body. We cannot comment on any bone-specific temporal 






could occur even earlier than day 3 in bones other than the tibia. But overall bone 
resorption is increased on day one, without observed an observed increase in serum 
osteocalcin, indicative of elevated bone formation.   
• Relative to non-irradiated bone marrow, the number of TRAP+, multinucleated 
osteoclasts from marrow harvested one day after irradiation and cultured for one week 
is significantly increased (~400% increase). Thus, radiation induces an increase in 
osteoclast number that can be identified both from histological samples and in vitro 
within the first week of irradiation.   
• In vitro mineral resorption is significantly elevated after irradiation. From marrow 
harvested one day after irradiation and cultured for two weeks on HA disks, the total 
resorption area and average size of the resorption sites are greater following 
irradiation. Thus, a radiation-induced increase in the number of osteoclasts and 
subsequent increase in resorption likely is a factor that leads to bone atrophy. These 
changes occur within the first two weeks after radiation from the mouse bones we 
have examined. 
 
7.1.4 Conclusions Chapter 6 
• Irradiating the right hind limb of rats with doses of X-rays modeling what the pelvic 
bones surrounding a tumor would receive during radiotherapy does not induce an 
observed difference in body mass or long bone length (growth) during the course of a 
4 week study. Body mass imparts loads on bones, which (if changed relative to 






• BV/TV is significantly reduced in irradiated rats relative to control by Week 2 after 
exposure. The reduced bone volume occurred concurrently with decreased 
connectivity of the trabecular network, trabecular number, and increased presence of 
less efficient, rod-like trabeculae. These changes occur without corresponding changes 
in body mass. Thus atrophy and compromised trabecular microarchitecture were 
present by two weeks after exposure to clinically-modeled radiation. 
• Some recovery of the compromised trabeculae was observed in the irradiated-only rat 
tibiae by Week 4, particularly recovery of BV/TV. However connectivity of the 
network remained reduced, as did number of struts.  
• The trabeculae within irradiated (no drug) rat tibia are qualitatively odd in appearance 
and quantitiatively thicker, even by Week 2. The pattern of thicker trabeculae is 
inconsistent with trends typically associated with conditions of elevated resorption. 
Odd, thick trabeculae and irregular bone growths within irradiated metaphyses have 
been described in previous studies (Rohrer et al., 1979; Sawajiri and Mizoe, 2003), 
attributed with active production of osteoid from remaining osteoblasts (Rohrer et al., 
1979). Thick trabeculae also surround a consistently located area absent of bone within 
irradiated metaphyses of these rats. It may also be possible that increased strains 
within the struts surrounding a gap in the trabecular network could induce the 
remaining osteoblasts to remodel the trabeculae into thicker structures (Robling et al., 
2006). 
• Administration of risedronate, an antiresorptive agent capable of reducing osteoclast 






microarchitecture. Connectivity of the trabecular network is reduced compared with 
control by Week 2 after exposure. However the effects observed in the irradiated only 
group in terms of BV/TV, Tb.N, Tb.Sp, and SMI are not present within the irradiated 
+ risedronate group at this time. The difference in connectivity between these 
bisphosphonate-treated rats and controls was also smaller then what was present in the 
Irr group (12 % sparing effect). By Week 4, recovery of the trabecular network in 
terms of bone histomorphometric parameters is observed among the irradiated + 
risedronate treated animals. By reducing turnover and osteoclast activity, risedronate 
seems to reduce atrophy in rat bones observed at Week 2 and Week 4. 
 
 
7.2  Recommendations 
Many questions remain regarding the effects of ionizing radiation on osteoclast 
health, number, and function. This dissertation described increased activation and atrophy 
following radation. However, no study examined the mechanism leading to an increase in 
osteoclast activity. Our examinations of irradiated bones occurred between three days and 
four weeks after exposure. It is unclear if these observations within the first month 
remain true at longer durations after exposure. Also, the relationship between radiation-
induced microarchitectural changes and bone strength remains unclear, particularly in 
context of how antiresorptive therapies can affect both parameters. Ultimately, the goal is 
to prevent fractures among cancer patients receiving radiotherapy, so this final question 






7.2.1  Expansion of the Mouse Model 
A thorough time course study should be performed in order to better describe the 
mechanisms leading to induced osteoclast number and activity within tibiae.  We used an 
orthovoltage irradiator at Clemson University. Therapeutic irradiations are performed 
with higher energy X-rays (i.e, 6 MV). To provide further evidence of osteoclast number 
and activity after a single radiation exposure, groups of mice (B6) should be exposed to 6 
MV X-rays (2 Gy total body exposure). The study should evaluate bone volume and 
architectural changes at this energy (via microCT) as well as histological impacts of 
radiation. Examination at very early (1 hour), early (Day 2, Day 4, Day 7), and later (Day 
10, Day 14, Day 19, Day 21, Day 28) time points should be performed in order to 
establish a time course response of bone and bone cells to irradiation.  Particularly, one 
focus of the histological investigation should be to provide insight into the cause of any 
increase in osteoclast number. Conditions such as chronic oxidative stress and 
inflammation have been documented in irradiated tissues and are associated with 
radiation-induced late effects (Bentzen, 2006; Robbins and Diz, 2006; Robbins and Zhao, 
2004; Stone et al., 2003; Vujaskovic et al., 2001). Both of these conditions can induce an 
increase in osteoclast activity (Bai et al., 2005; Clowes et al., 2005; Lam et al., 2000; 
Lean et al., 2005). Therefore stains should be used to identify cells apoptosis (e.g., 
TUNEL), inflammation (i.e., immunohistochemistry for macrophages, TNFα, IL-1), ROS 
(e.g., Amplex red), and how these correlate with any observed changes in osteoblast and 







7.2.2 Effects of Radiation on Osteoclast Proliferation and Activity Under Different In 
Vitro Conditions  
To date the effects of radiation on osteoclast function have been described from 
cultured bone marrow. While an increase has been documented, the nature of the 
increased number and resorption remains unclear. Could radiation induce direct effects 
on mature osteoclasts present within the marrow that increases resorptive capacity? How 
are osteoclast differentiation and proliferation affected by ionizing radiation both 
independently of the marrow microenvironment as well as from within irradiated 
marrow? Future studies should examine irradiated cell cultures in order to further identify 
how osteoclast number and resorption is stimulated by radiation. For example, separate 
studies could examine irradiated cultures of mature osteoclasts, osteoclast progenitors, 
osteoclast progenitors + mature osteoblasts, and/or irradiated marrow (representing 
osteoclasts, osteoclast progenitors, and other elements within the marrow capable of 
inducing osteoclast activity including osteoblasts and inflammatory cells). Cells could 
also be cultured on top of HA disks and be used to assess how differentiation, resorption, 
or proliferation are affected by radiation in each of these environments. Agents could be 
added to each culture before or after irradiation that may influence the affects of radiation 
on resorption. Such factors could include α-La, hydrogen peroxide, antibodies for TNFα, 









7.2.3 Correlation between radiation-induced changes in bone and femoral neck strength 
The femoral neck is the most frequently fractured location in patients receiving 
radiation therapy for pelvic tumors (Baxter et al., 2005b). In this dissertation, 
bisphosphonates proved useful in preventing deterioration of the microarchitecture within 
the tibia by week 4. The tibia is a useful model for comparative purposes as many studies 
use microCT to describe changes in trabecular bone of the proximal tibia following 
various challenges. Future studies need to assess how changes of trabecular and cortical 
bone within femoral regions of interest following clinically-modeled irradiation translate 
into changes in strength, specifically within the femoral neck and large muscle 
attachment sites such as the greater trochanter. Rats would be the preferred animal model, 
since the size of the femur permits mechanical testing of the femoral neck. MicroCT 
assessments of trabecular and cortical bone could be performed prior to mechanical 
testing of the neck. Methods should be adapted using conventional microCT to identify 
site-specific changes in trabecular bone. Tibial and femoral microCT could be performed 
using the same irradiation protocol and risedronate-treated groups used in Chapter 6 of 
this dissertation, only examinations would be performed at Week 2, 4, and 6, with 
subsequent examinations at 6 months and 1 year after exposure. Therefore, this study 
would not only provide some insight into short (<6 month) and long (6-12 month) term 
correlation between radiation, bone morphology, and strength, but also if an 
antiresorptive agent might be useful for consideration as a way to prevent fractures 
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